Gene Data From HGNC: https://www.genenames.org/download/statistics-and-files/
Symbol:
IFNE
Name:
interferon epsilon
Location:
09p21.3
Locus Group:
protein-coding gene
Gene Type:
Protein Coding
Locus Type:
gene with protein product
Clinical Trials Data: https://classic.clinicaltrials.gov/api/gui/ref/download_all
Clinical Studies
| NCT Number | Status | Brief Title | View |
|---|---|---|---|
| NCT00001763 | Subcutaneously Administered Interleukin-12 Therapy in HIV-Infected Patients With Disseminated Mycobacterium Avium Complex Infection | View | |
| NCT00973219 | Hepatitis B Surface AntigenHBsAg Loss in Chronic Hepatitis B Patients With Low Viral Load | View | |
| NCT00001830 | Donor Th2 Cells to Prevent Graft-Versus-Host Disease in Bone Marrow Transplants | View | |
| NCT00000694 | A Phase I Trial of Recombinant Human Granulocyte-Macrophage Colony Stimulating Factor rHuGM-CSF Recombinant Alpha Interferon and Azidothymidine AZT in AIDS-Associated Kaposis Sarcoma | View | |
| NCT00001438 | A Pilot Study of the Combination of Retinoic Acid and Interferon-Alpha2a for the Treatment of Lymphoproliferative Disorders in Children With Immunodeficiency Syndromes | View | |
| NCT00001567 | A Phase II Efficacy Study of Roferon-A in Hairy Cell Leukemia | View | |
| NCT00029107 | Rituximab to Treat Hepatitis C-Associated Cryoglobulinemic Vasculitis | View | |
| NCT00043316 | Interferon Gamma-1b by Inhalation for the Treatment of Patients With Cystic Fibrosis | View | |
| NCT00111397 | Adjuvant Cytokine Therapy to Treat Pulmonary Mycobacterium Avium Complex Infection | View | |
| NCT00154869 | Peginterferon Alfa-2a Plus Ribavirin for Chronic Hepatitis CHepatitis B Co-Infection and Chronic Hepatitis C | View | |
| NCT00172445 | Clinical Studies of Kikuchis Disease | View | |
| NCT00209118 | Paroxetine for the Treatment of Interferon Related Side Effects for Hepatitis C | View | |
| NCT04568096 | Combination of Chemopreventive Agents All- Trans Retinoic Acid and Tamoxifen as Potential Treatment for the Lung Complication of COVID-19 | View | |
| NCT02323269 | Effectiveness of DMF Dimethyl Fumarate and Its Impact on PROs Patient Reported Outcomes in Treatment-Naive or Suboptimal IFN Interferon or GA Glatiramer Acetate Responders With RRMS ImPROve | View | |
| NCT03291639 | Functional Plasticity of Human IL-17-producing CD8 T Cells | View | |
| NCT00257907 | Immune Response to Mycobacterium Tuberculosis Infection | View | |
| NCT00275938 | Interferon Alpha 2b Plus Ribavirin for Chronic Hepatitis B | View | |
| NCT00288990 | A Serologic Study to Correlate Beta-IFN NAb Titers to Beta-IFN Induced Biomarker Response in Patients With Multiple Sclerosis | View | |
| NCT04048018 | Performance Evaluation of the VIDAS TB-IGRA Assay | View | |
| NCT00311220 | Use TST and QFT-RD1 Test to Monitor the Tuberculous Infection in Patients Close Contact People and Health Care Workers | View | |
| NCT00491179 | Retreatment of Dialysis Patients With Chronic Hepatitis C With Pegylated Interferon Alfa-2a Plus Low Dose Ribavirin | View | |
| NCT00491244 | Pegylated Interferon Alfa-2a Plus Low Dose Ribavirin for Treatment-Naïve Hemodialysis Patients With Chronic Hepatitis C | View | |
| NCT00535236 | A Study of an Investigational V212Heat-Treated Varicella-Zoster Virus VZV Vaccine in Immunocompromised Adults V212-002 | View | |
| NCT00597259 | Pegasys Plus Entecavir Versus Entecavir Alone for Hepatitis Be Antigen-Positive Chronic Hepatitis B | View | |
| NCT00611611 | BLYS and IFN in SLE | View | |
| NCT00707317 | T Cell Interferon-gamma Release Assay TIGRA in Immunocompromised Individuals | View | |
| NCT00772408 | Toll-like Receptor 2 Gene Polymorphism Serum Cytokines and Susceptibility to Disease Severity or Treatment Response of Pulmonary Tuberculosis | View | |
| NCT00819806 | CpG 7909Montanide ISA 720 With or Without Cyclophosphamide in Combination Either With NY-ESO-1-derived Peptides or the NY-ESO-1 Protein for NY-ESO-1-expressing Tumors | View | |
| NCT00871533 | Pilot Study of IFN α2b for Melanoma Patients | View | |
| NCT00963261 | Quality of Life and Psychological Well-being in Patients With Malignant Melanoma | View | |
| NCT00173212 | Proliferation of Endometrial Stromal Cells in Adenomyosis | View | |
| NCT00943982 | The Treatment of Uveitic Cystoid Macular Edema With Topical Interferon Gamma | View | |
| NCT00977054 | Double Filtration Plasmapheresis for Hepatitis C Virus HCV Genotype 1 Patients With High Viral Load | View | |
| NCT00980161 | Micro RNA-122 and the Clinical Course of Patients With Chronic Hepatitis C | View | |
| NCT00980213 | Evaluation of the Cost and Effectiveness Sunitinib Compared to Interferon-Alfa in Finland | View | |
| NCT01006031 | Retreatment With High Doses of pegIFN Alfa-2a and Ribavirin of Previous Nonresponders HIV-coinfected Patients With Cirrhosis Due to HCV 1-4 | View | |
| NCT01116791 | Cytoreductive SurgeryCRS Plus Hyperthermic Intraoperative Peritoneal ChemotherapyHIPC With Cisplatin to Treat Peritoneal Carcinomatosis From Upper Gastrointestinal Cancer | View | |
| NCT01191034 | Peptide Vaccination Associated With Tumoral Immunomodulation in Patients With Advanced Metastatic Melanoma | View | |
| NCT01195181 | Different PEG-interferon and Ribavirin Schedules for Chronic Hepatitis C in the Real Clinical Practice | View | |
| NCT00115908 | A Study of Albuferon and Ribavirin in Interferon Naive Subjects With Chronic Hepatitis C Genotype 1 | View | |
| NCT01340222 | Monocyte Chemotactic Protein-1 MCP-1 Expressing Monocytes to Predict Preterm Delivery PhenoMAP Study | View | |
| NCT01374711 | The Effects of Immunostimulation With GM-CSF or IFN-y on Immunoparalysis Following Human Endotoxemia | View | |
| NCT01413295 | Randomized Trial With Dendritic Cells in Patients With Metastatic Colorectal Cancer | View | |
| NCT01437969 | Pharmacogenomics Study on IL28B Genetic Variants in Italian Patients With HCV Infection naïve to Treatment | View | |
| NCT01443923 | Boceprevir Drug Combination for Hepatitis C Treatment in People With and Without HIV | View | |
| NCT01468337 | Topical Interferon Gamma-1b for Central Serous Chorioretinopathy | View | |
| NCT01567540 | A Pilot Study Evaluating Safety of Sitagliptin Combined With Peg-IFN Alfa-2a Ribavirin in Chronic Hepatitis C Patients | View | |
| NCT02364986 | Immune- and miRNA-response to Recombinant Interferon Beta in Healthy Volunteers and Patients With Relapsing Remitting Multiple Sclerosis | View | |
| NCT01658774 | Impact of Repeated Anthelmintic Treatment on the Risk of Malaria in Kenyan School Children | View | |
| NCT01681446 | Adjuvant IFN-α for Patients Underwent Curative Surgery for HCC With a Low miR-26 Expression | View | |
| NCT01725204 | Safety and Efficacy of Pegylated IFN-alpha 2B Added to Dasatinib in Newly Diagnosed Chronic Phase Myeloid Leukemia | View | |
| NCT01729663 | Phase IIIII Clinical Study CSF470 Plus BCG Plus GM-CSF vs IFN Alpha 2b in Stage IIB IIC and III Melanoma Patients | View | |
| NCT00297570 | Imatinib Versus Imatinib and Peg-Interferon in Patients With Ph CML and Complete Cytogenetic Response After Imatinib Therapy | View | |
| NCT01815918 | Effect of Low Dose Corticosteroids on Perioperative Markers of Thrombosis and Fibrinolysis in Total Knee Arthroplasty | View | |
| NCT02880046 | Study of Polyfunctionality of Anti-tumor T Lymphocytes in Cancerology Potential Biomarker for Emerging Immunotherapies | View | |
| NCT01857245 | Intensive Models of HCV Care for Injection Drug Users | View | |
| NCT01858909 | Efficacy of Melatonin in Patients With Severe Sepsis or Septic Shock | View | |
| NCT01908049 | Treatment With Probiotics Saccharomyces Boulardii and Its Role in Bacterial Translocation and Immune Reconstitution in VIH Infection | View | |
| NCT01925820 | Pegasys Plus Entecavir Versus Entecavir Versus Pegasys for Hepatitis B e Antigen-Negative Chronic Hepatitis B | View | |
| NCT01945008 | Observational Study in HCV Chronic Infection | View | |
| NCT01964742 | Analysis of Host Genetic Factors in the Occurrence of Anemia and on the Virological Response to a Peg-interferonRibavirin Therapy in HIV-HCV Co-infected Patients | View | |
| NCT00005665 | Ingested Interferon Alpha Prolongation or Permanence of the Honeymoon Phase in Newly Diagnosed Type 1 Diabetes Mellitus | View | |
| NCT02008214 | Efficacy of PTXIFN Alpha RBV on Hepatitis C Virus Coinfected HIV Patients | View | |
| NCT02062476 | Epigenetic Effects Elicited By Lactobacillus GG In Children With Cows Milk Allergy | View | |
| NCT02882659 | Dendritic Killer Cell-based Immunotherapy for Solid Tumors | View | |
| NCT02124044 | Safety Tolerability and Efficacy of Asunaprevir and Daclatasvir in Subjects Coinfected With HIV-HCV | View | |
| NCT02466035 | Epigenetic Effects Involved in Children With Cows Milk Allergy EPICMA | View | |
| NCT03837444 | Microvesicles and Monocytes to Predict Mortality of Patients With Cirrhosis | View | |
| NCT02507882 | Impact of IL-28B rs12979860 and rs4803217 Gene Polymorphisms Associated With miRNAs Deregulation on HCV-related Hepatocellular Carcinoma | View | |
| NCT02848144 | Pediatric Immune Response to Infectious Shock | View | |
| NCT02891213 | Study of the Role of Soluble Forms of RAGE sRAGEesRAGE as Diagnostic and Prognostic Biomarkers of Systemic Lupus Erythematosus | View | |
| NCT02948426 | Intraperitoneal Infusion of Autologous Monocytes With Sylatron Peginterferon Alfa-2b and Actimmune Interferon Gamma-1b in Women With Recurrent or Refractory Ovarian Cancer Fallopian Tube Cancer or Primary Peritoneal Cancer | View | |
| NCT05392387 | Treatment and Prognosis of Patients With Chronic HBV Infection | View | |
| NCT02959359 | DAA in the Risk of Recurrence After Curative Treatment of HCC | View | |
| NCT03042481 | Off-therapy Response After Stopping Entecavir or Tenofovir | View | |
| NCT03123016 | Combined Therapy With Narrow-Band Ultraviolet B Phototherapy and Apremilast for the Treatment of Vitiligo | View | |
| NCT00178763 | Hyperthermia With Chemotherapy for Locally Advanced or Metastatic Pancreas Cancer | View | |
| NCT03212833 | Impact of Insulin Resistance on Therapeutic Response for Oral Treatment of Chronic Hepatitis C Virus Infection | View | |
| NCT03262051 | Impact of Acute and Chronic Inflammation on Cytochromes P450 Activity Measured With Dried Blood Spot | View | |
| NCT03313154 | Impact on QoL and Cognitive Functioning of New Antiviral Therapies in Subjects With Chronic Hepatitis HCV-related | View | |
| NCT01025765 | The Effects of Oral Hypoglycemic Agents on Chronic Hepatitis C Patients Receiving Peg-Intron Plus Ribavirin | View | |
| NCT00601016 | A Phase II Study of Imiquimod 5 Cream for the Treatment of Hemangioma in Infancy | View | |
| NCT00553930 | Low Dose Peginterferon-α 2a for Chronic Hepatitis C Genotypes 2 or 3 in HIV-coinfected Patients | View | |
| NCT05034055 | Study of Stereotactic Ablative RadiotherapySBRT Followed by Atezolizumab Tiragolumab in Treatment-naive Patients With Metastatic Non-small Cell Lung Cancer | View | |
| NCT01034644 | Pharmacogenetic Trial and Long-term Follow-up of the PRISMS Trial PRISMS-15 | View | |
| NCT03795649 | The Immunomodulatory Effect of Antrifibrinolytic Tranexamic Acid in Total Knee Arthroplasty | View | |
| NCT03827278 | Comparative Study of Human Immunodeficiency Virus Negative Host Talaromyces Between Voriconazole and Amphotericin Sequential Itraconazole Therapy | View | |
| NCT03859570 | Pentoxifylline in Lupus Nephritis | View | |
| NCT04344548 | Adoptive Cell Transfer for the Immunotherapy of COVID-19 in Colombia | View | |
| NCT04278547 | Multicenter Clinical Trial to Evaluate the Efficacy of a Preventive Strategy Against CMV Infection in Heart Transplant Patients Based on the Specific T Cells Response | View | |
| NCT05157204 | Measurment of Interleuukin-6 at Exhaled Breath Condensate of Covid-19 Patients and Post Covid-19 Patients With Lung Fibrosis Randomized Controlled Study | View | |
| NCT04100902 | The Effect of Allergen Immunotherapy on Anti-viral Immunity in Patients With Allergic Asthma | View | |
| NCT04133948 | Multicenter Phase 1b Trial Testing the Neoadjuvant Combination of Domatinostat Nivolumab and Ipilimumab in IFN-gamma Signature-low and IFN-gamma Signature-high RECIST 11-measurable Stage III Cutaneous or Unknown Primary Melanoma | View | |
| NCT04184700 | Epigenetic Effects in Children With Cows Milk Allergy Treated With Different Formulas | View | |
| NCT00823862 | Safety Study of SD-101 a Novel C Type Toll-like Receptor 9 TLR9 Agonist for the Treatment of Chronic Hepatitis C Virus HCV Infection | View | |
| NCT05222347 | Immunomodulatory and Preventive Effects of Olive Leaf Tea Against COVID-19 | View | |
| NCT04356417 | Long-term Use of Drugs That Could Prevent the Risk of Serious COVID-19 Infections or Make it Worse | View | |
| NCT04350281 | Double Therapy With IFN-beta 1b and Hydroxychloroquine | View | |
| NCT04353180 | Assessment the Activity Value of Isotretinoin 13- Cis-Retinoic Acid in the Treatment of COVID-19 Isotretinoin in Treatment of COVID-19 Randomized | View | |
| NCT04372199 | SEVERITY SCORE FOR COVID-19 PNEUMONIA | View | |
| NCT04376476 | Host-pathogen Interactions During SARS-CoV-2 Infection | View | |
| NCT04385095 | Trial of Inhaled Anti-viral SNG001 for SARS-CoV-2 COVID-19 Infection | View | |
| NCT04402203 | Study on Safety and Efficacy of Favipiravir Favipira for COVID-19 Patient in Selected Hospitals of Bangladesh | View | |
| NCT04438564 | Immunoassay and Regulation of Traditional Chinese Medicine on Cancer Patients | View | |
| NCT04469153 | Interest of the Dosage of Ferritin Glycosylated Ferritin in COVID-19 | View | |
| NCT04462120 | IL-12RB and TNF-alpha Gene Polymorphism and Susceptibility and Progress of Covid-19 SARS-CoV-2 A Case Control Study | View | |
| NCT04822909 | A Study to Evaluate the Efficacy and Safety of Apremilast in Patients of Chronic and Recurrent Erythema Nodosum Leprosum | View | |
| NCT04465695 | Dual Therapy With Interferon Beta-1b and Clofazimine for COVID-19 | View | |
| NCT05144698 | RAPA-201 Therapy of Solid Tumors | View | |
| NCT04577378 | Efficacy and Safety of Drug Combination Therapy of Isotretinoin and Some Antifungal Drugs as A Potential Aerosol Therapy for COVID-19 An Innovative Therapeutic Approach COVID-19 | View | |
| NCT04640129 | HBsAg Seroclearance in Adults With HBV Related Liver Fibrosis After Receiving Combined Therapy of Peg-IFN and Tenofovir | View | |
| NCT04646980 | BiobranMGN-3 Increases Innate Resistance and Reduces the Incidence of Influenza-like Illnesses | View | |
| NCT00381953 | High-dose IFN and PEG IFN for Induction Therapy in Difficult to Treat Genotype 1 Patients With Chronic HCV | View | |
| NCT04727593 | The Modulatory Role of Internet MBCT on Extracellular Vesicles and Distress in Cancer Patients - Study Protocol | View | |
| NCT04768517 | HCV Reinfection in in HIVHCV-coinfected Patients Achieving SVR by Antiviral Therapy | View | |
| NCT04777981 | CBDRA60 to Prevent or Reduce Symptoms of COVID-19 and Prevention of Post-Acute Sequelae of SARS-CoV-2 Infection PASC | View | |
| NCT04793568 | Human Recombinant Interferon Gamma-1b for the Prevention of Hospital-acquired Pneumonia in Critically Ill Patients a Double-blind International Phase 2 Randomized Placebo-controlled Trial - the PREV-HAP Study | View | |
| NCT00527540 | Effectiveness and Side Effects of Pegylated Interferon Alpha-2a Pegaferon Plus Ribavirin in the Patients With Chronic Hepatitis C | View | |
| NCT00015652 | Interleukin-2 IL-2 Pegylated Interferon PEG-IFN Alfa-2b and Ribavirin RBV Treatment in Patients With Hepatitis C and HIV Coinfection | View | |
| NCT04916756 | A Prospective Pilot Study to Explore Efficacy and Safety of Baricitinib in Active Primary Sjogrens Syndrome Patients | View | |
| NCT04934527 | Association of T Gamma Delta-CD16 Cells and Anti-CMV Immunoglobulins in the Prevention of CMV Infection | View | |
| NCT04972760 | Baricitinib in Patients With Relapsing or naïve Dermatomyositis | View | |
| NCT05005637 | The Effectivity of Anti Tuberculosis Therapy in Idiopathic Uveitis With Positive IGRA | View | |
| NCT05019456 | Exercise and COVID-19 Viral T-cell Immunity | View | |
| NCT05077813 | Utilizing the Crosstalk Among Chicoric Acid 13-Cis Retinoic AcidAerosolized Minocycline and Vitamin D as a Potent Quadrate Therapy for Treating Patients With Multidrug-resistant TB and Patient With Both Multidrug-resistant TB and COVID-19 | View | |
| NCT05094596 | Effect of Montelukast Therapy on Clinical Course Pulmonary Function and Mortality in Patients With COVID-19 | View | |
| NCT05100043 | Interleukin 4 and Interferon Gamma Predictors of Human Papillomavirus Immunotherapy in Warts | View | |
| NCT00322179 | Microarray Analysis of IFN-Induced Gene Expression in Obese and Non-Obese Patients With Chronic Hepatitis C | View | |
| NCT06327321 | Vitiligo Treatment by Targeting TYK2 Mediated Responses | View | |
| NCT05202548 | Immunology Dysregulation in Lymphadenitis Tuberculosis An Observational Study Using Patient Block Paraffins 2019 Until 2021 | View | |
| NCT05208528 | Effect of the Probiotic ES1 and Its Inactivated Form HT-ES1 Over Symptomatology Asociated With Allergic Rhinitis | View | |
| NCT01075763 | A Pilot Trial of Interferon Beta-1a in Alzheimers Disease | View | |
| NCT05286047 | Probiotic on Atopic Dermatitis in Infant | View | |
| NCT02332486 | Based on Metabonomics Dryness Pathogen Type of OLP a Dynamic Study | View | |
| NCT05440747 | Treatment Free Remission TFR in CML Patients CML-CPStudy | View | |
| NCT05463133 | Allogeneic Hematopoietic Stem Cell Transplantation for Chronic Granulomatous Disease CGD With an Alemtuzumab Busulfan and TBI-based Conditioning Regimen Combined With Cytokine IL-6 - IFN-gamma Antagonists | View | |
| NCT05573438 | Acute Inflammatory and Metabolic Effect of High Fructose Intake | View | |
| NCT05589909 | Performance of Interleukin-27 Cord Blood Level as A Biomarker Predicating Early Onset Neonatal Sepsis | View | |
| NCT05633927 | Humoral and Cellular Immunity Against SARS-COV-2 Vaccine in HIV-infected Patients Immunosuppressed | View | |
| NCT05182515 | Plasma Exchange in Covid-19 Patients With Anti-interferon Autoantibodies | View | |
| NCT05797597 | Long-term Aspirin Therapy as a Predictor of Decreased Susceptibility to SARS-CoV-2 Infection in Aspirin-Exacerbated Respiratory Disease | View | |
| NCT03209011 | The Changes of CD4T Cells Frequency and Function During Antiviral Therapy | View | |
| NCT00328549 | A Study to Evaluate the Erythropoietic Response in Hepatitis C Virus HCV Patients Receiving Combination Ribavirin RBVInterferon IFN Therapy or RBVPEG IFN NATURAL HISTORY-HCV | View | |
| NCT05850273 | Mechanism of Action of Interferon in the Treatment of Myeloproliferative Neoplasms | View | |
| NCT05654818 | Peripheral Immunological Effects of High-dose Vitamin D Treatment in Healthy Subjects | View | |
| NCT06017310 | Respiferon Project | View | |
| NCT06032923 | Double-blind Placebo Controlled Study to Evaluate the Effect of NAD Boosting With Nicotinamide Riboside on Immunometabolism and Immunity in Systemic Lupus Erythematosus | View | |
| NCT00000695 | Open Label Phase I Study To Evaluate the Safety of Combination Therapy With AZT and Interferon-Beta in Patients With AIDS Related Kaposis Sarcoma | View | |
| NCT06152367 | Immunization With Autologous Dendritic Cells and Tumor Lysates in Melanoma Patients | View | |
| NCT02765594 | Hydroxychloroquine Sulfate Alleviates Persistent Proteinuria in IgA Nephropathy | View | |
| NCT00404352 | REbif FLEXible Dosing in Early Multiple Sclerosis MS | View | |
| NCT06261073 | Evaluation of Serum and Tissue Cathepsin L in Non-segmental Vitiligo Patients | View | |
| NCT00057447 | Safety of Interferon Gamma-1b With Rituximab in Non-Hodgkins Lymphoma Patients | View | |
| NCT02416531 | Vulvar Lichen Sclerosus Comparison Between Clobetasol Propionate Photodynamic Therapy and Low-Intensity Laser | View | |
| NCT05104723 | Safety and Efficacy of Tofacitinib for Chronic Granulomatous Disease With Inflammatory Complications | View | |
| NCT02282709 | Effect of ASV and DCV Therapy on the Quality of Immune Status in Chronic HCV Patients | View | |
| NCT06356740 | Efficacy and Tolerance of AbacavirLamivudine Treatment in Patients With Systemic Lupus Erythematosus | View | |
| NCT06365359 | Systemic Lupus Erythematosus and Chlordecone Impregnation in Martinique | View | |
| NCT06375642 | A Single Arm Single Centered Phase II Trial on the Combination of Adebrelimab Surufatinib and Irinotecan Liposome-based HAIC in Advanced iCC | View | |
| NCT03067155 | CMV Specific T Cell Therapy After Allogeneic Stem Cell Transplantation | View | |
| NCT06545955 | A Trial to Evaluate Intravesical Nadofaragene Firadenovec Alone or in Combination With Chemotherapy or Immunotherapy in Participants With High-grade BCG Unresponsive Non-muscle Invasive Bladder Cancer | View | |
| NCT03815578 | Evaluation of Pain Sensitization in Rheumatoid Arthritis Analysis on a Cohort of Tofacitinib Treated Patients | View | |
| NCT05190250 | Pro-inflammatory Cytokines and Implantation Process in Women With Primary Idiopathic Infertility | View | |
| NCT04396067 | Aerosol Combination Therapy of All-trans Retinoic Acid and Isotretinoin as A Novel Treatment for Inducing Neutralizing Antibodies in COVID -19 Infected Patients Better Than Vaccine An Innovative Treatment | View | |
| NCT01087944 | A Study of Administration of Peginterferon Alfa-2a Pegasys by Autoinjector Versus Pre-filled Syringe in Patients With Chronic Hepatitis C | View | |
| NCT04552379 | The Containing Coronavirus Disease 19 COVID-19 Trial | View | |
| NCT01125228 | Effectiveness of Zidovudine vs Zidovudine Plus Alpha Interferon vs Interferon for Treatment of HIV | View | |
| NCT03050905 | Proof of Concept Study To Evaluate the Efficacy and Justification Of OBVPTVr and DSV In Adults With Chronic Hepatitis C Virus Genotype 2K1B | View | |
| NCT03937895 | Allogeneic NK Cell SMT-NK in Combination With Pembrolizumab in Advanced Biliary Tract Cancer | View | |
| NCT01123655 | Phase 1 Trial of Type II Collagen CII APL A12 in Rheumatoid Arthritis Patients | View | |
| NCT02540395 | Prospective Donor Specific T Response Measurment for IS Minimization in de Novo Renal Transplantation | View | |
| NCT01121731 | A Phase III Clinical Trial With Interferon Alfa 5 in Treatment-Experienced Patients With Genotype-1 Chronic Hepatitis C | View | |
| NCT02336399 | Sustained HBsAg and Viral Response in Patients Achieved HBsAg Loss by Interferon Treatment | View | |
| NCT00211887 | Combination Therapy in Patients With Relapsing-Remitting Multiple Sclerosis MSCombiRx | View | |
| NCT00336557 | Determine Impact of Multiple NAb Tests on Treatment Compared to Usual Care of MS Patients on High-dose IFN Therapy | View | |
| NCT04320303 | CMV Infection and Immune Intervention After Transplantation | View | |
| NCT00085670 | Cytokine Gene Polymorphisms in Bone Marrow Failure | View | |
| NCT00001428 | A Phase II Study of 5-Fluorouracil Administered as a One Hour Infusion in Combination With Calcium Leucovorin and Interferon Alpha-2A in Advanced Colorectal Cancer | View | |
| NCT04334044 | Treatment of SARS Caused by COVID-19 With Ruxolitinib | View | |
| NCT01183169 | Efficacy and Safety of Adding Alisporivir DEB025 to Peginterferon IFN Alfa-2a Peg-IFN Alfa-2a and Ribavirin in Chronic HCV Genotype 1 Patients Who Relapsed or Did Not Respond to Previous Treatment | View | |
| NCT00043342 | Study of Interferon Gamma-1b by Injection for the Treatment of Patients With Cystic Fibrosis | View | |
| NCT00245414 | Trial of Pegasys in Patients With Chronic Hepatitis C | View | |
| NCT00057616 | Study to Compare the Efficacy and Safety of CC-5013 vs Placebo in Subjects With Metastatic Malignant Melanoma | View | |
| NCT00059878 | Voriconazole With or Without Interferon Gamma in Treating Patients With Aspergillosis or Other Fungal Infections | View | |
| NCT00002270 | A Pilot Study of the Efficacy of Recombinant Alpha Interferon IFN-A2b and Zidovudine AZT in the Treatment of Progressive Multifocal Leukoencephalopathy PML Complicating HIV-1 Infection | View | |
| NCT00002078 | Phase I Study of Alferon N Injection in Persons With Asymptomatic Human Immunodeficiency Virus HIV Infection | View | |
| NCT01650389 | Safety and Immunogenicity of MVA85A Prime and Bacille Calmette-Guerin Boost Vaccination | View | |
| NCT00001296 | A Randomized Phase III Trial of Hyperthermic Isolated Limb Perfusion With Melphalan Tumor Necrosis Factor and Interferon-Gamma in Patients With Locally Advanced Extremity Melanoma | View | |
| NCT01651728 | Effect of Simvastatin on Pneumonia Prognosis in Elderly Patients | View | |
| NCT01710501 | A Study of Different Doses of Grazoprevir MK-5172 Given With Pegylated Interferon Alfa-2b and Ribavirin to Treatment-Naïve Participants With Chronic Hepatitis C MK-5172-038 | View | |
| NCT00473213 | Optimizing IFN Beta - 1B Dose | View | |
| NCT01243281 | Pegylated Interferon Alpha-2b Monotherapy Versus Combination With Entecavir in HBeAg-negative Chronic Hepatitis B | View | |
| NCT00047645 | A Study of the Safety and Efficacy Interferon-Gamma 1b in Patients With Idiopathic Pulmonary Fibrosis IPF | View | |
| NCT00043329 | Post Marketing Surveillance Study of Actimmune in Patients With Severe Malignant Osteopetrosis | View | |
| NCT00052052 | An Open-Label Study of the Safety and Efficacy of Subcutaneous Recombinant Interferon-Gamma 1b IFN-Gamma 1b in Patients With Idiopathic Pulmonary Fibrosis IPF | View | |
| NCT01259934 | Nordic Adjuvant IFN Melanoma Trial | View | |
| NCT00370006 | Phase 1 Trial of CMV Towne Vaccine in Subjects Previously Received VCL CT02 Vaccine ID or IM | View | |
| NCT00077636 | ACCELERATE Study - A Study of PEGASYS Peginterferon Alfa-2a 40KD in Combination With COPEGUS Ribavirin in Interferon-Naive Patients With Chronic Hepatitis C CHC Infection | View | |
| NCT00078403 | Pegylated Interferon Alfa-2a Maintenance Therapy and Liver Disease Progression in People Infected With Both HIV and Hepatitis C Virus HCV | View | |
| NCT01277601 | Efficacy Safety of Tenofovir Disoproxil Fumarate TDF Plus Peginterferon α-2a Peg-IFN Versus TDF or Peg-IFN Monotherapy in Chronic Hepatitis B | View | |
| NCT01276847 | A Study to Assess the Effect of Ustekinumab Stelara and Etanercept Enbrel in Participants With Moderate to Severe Psoriasis MK-0000-206 | View | |
| NCT00117533 | Pegylated Interferon Alfa-2b Plus Ribavirin in Chronic Hepatitis B and Delta | View | |
| NCT00378599 | Effects of Pegylated Interferon Alfa-2b and Ribavirin After Orthotopic Liver Transplantation in Subjects With Chronic Hepatitis C Recurrence P04590AM3COMPLETED | View | |
| NCT01311817 | Transcutaneous Immunization With an Attenuated Listeria Monocytogenes Vector Vaccine | View | |
| NCT00502034 | Low-dose IL-2 Plus IFN-alpha Immunotherapy as Adjuvant Treatment of Renal Carcinoma | View | |
| NCT00502099 | Comparison of Pegasys Versus Peg-Intron for Treatment of Chronic Hepatitis C Genotype 4 | View | |
| NCT00441103 | A Study to Evaluate Rebif New Formulation Interferon-beta-1a in Relapsing Remitting Multiple Sclerosis | View | |
| NCT00043355 | Safety and Efficacy of Inhaled Interferon Gamma-1b in Pulmonary MAC Infection | View | |
| NCT00192647 | A Study of Induction Dosing With Peginterferon Alfa-2a and Ribavirin in Participants With Chronic Hepatitis C CHC Genotype 1 Infection | View | |
| NCT00277758 | Safety Study of Low Dose Interleukin 2 IL-2 Plus PEG-IFNRBV In Chronic Hepatitis C Virus Genotype I | View | |
| NCT00420784 | A Study of Telaprevir VX-950 Pegasys and Copegus in Hepatitis C PROVE3 | View | |
| NCT00452023 | Pegasys in Patients With Myeloproliferative Diseases | View | |
| NCT01353911 | Grazoprevir MK-5172 Administered With Peginterferon and Ribavirin in Treatment-Naïve Participants With Chronic Hepatitis C MK-5172-003 | View | |
| NCT00445523 | Safety Study of TroVax Alone vs TroVax Plus Interferon Alpha in Patients With Renal Cancer | View | |
| NCT00303381 | Safety and Efficacy of Interferon-Beta-1a Rebif for Treating Subjects With Acute Symptoms of Ulcerative Colitis | View | |
| NCT01364090 | A Collaborative Trial in Injectors of Individualized Treatment for Genotype 23 | View | |
| NCT00329368 | Safety and Tolerability Study of FolateImmune in Combination With Cytokines in Patients With Refractory or Metastatic Cancer | View | |
| NCT00336479 | Phase 2 Study of VX-950 Pegasys and Copegus in Hepatitis C | View | |
| NCT01890083 | A Health Intervention to Prevent Depression Hepatitis C Patients | View | |
| NCT00372385 | Phase 2 Study of VX-950 Pegasys With and Without Copegus in Hepatitis C | View | |
| NCT00382798 | Adaptive Phase I HCV Study With Nucleoside Analogue in Combination With Interferon and Ribavirin | View | |
| NCT01404117 | A Multinational Randomized Double-blind Parallel-group Placebo-controlled Study Assessing the Safety and Tolerability | View | |
| NCT00411385 | Efficacy of Albumin Interferon Alfa-2b With Ribavirin Compared to Peg-IFN Alfa-2a With Ribavirin in IFN Naive Patients Geno23 | View | |
| NCT00428584 | RNF and Betaseron Tolerability Study | View | |
| NCT00424684 | Comparison of the Quantiferon-TB GOLD in Tube Assay With Tuberculin Skin Testing for Detecting Latent Tuberculosis Infection in Patients With Chronic Liver Disease Being Evaluated for or Awaiting Liver Transplantation | View | |
| NCT01150747 | Chlamydia Trachomatis Immunology and Vaccinology Study | View | |
| NCT00447356 | High-Dose Interferon Alfa in Treating Patients With Stage II or StageIII Melanoma | View | |
| NCT00456469 | Diagnosis of Active and Latent TB Infection With IFN-y Assays in African Children | View | |
| NCT02814617 | The Efficacy and Safety of Cordyceps Sinensis Mycelium Culture ExtractPaecilomyces Hepiali CBG-CS-2 on Promotion of Immunity | View | |
| NCT00466219 | RibavirinPegasys Treatment of Recurrent Hepatitis C After Liver Transplant | View | |
| NCT01467479 | A Study to Treat Subjects With Telaprevir Ribavirin and Peginterferon Who Are Coinfected With HIV and Hepatitis C Virus HCV | View | |
| NCT00483184 | Low Dose Interferon Alpha Treatment for Oral Ulcers of Behcets Disease | View | |
| NCT01467505 | An Open Label Study of the Effect of Telaprevir in Combination With Ribavirin and Peginterferon on HCV Infection in Stable Liver Transplant Patients | View | |
| NCT01467492 | Telaprevir Peg-IFN-alfa-2a and RBV in Treatment-Experienced BlackAfrican American and Non-BlackAfrican American Subjects With Genotype 1 Chronic Hepatitis C | View | |
| NCT02690103 | Response Modifier Arabinoxylan Rice BranMGN-3Biobran With Interferon-Alpha for HCV | View | |
| NCT00495768 | Reducing Depressive Symptoms During HCV Therapy A Randomized Study | View | |
| NCT00493116 | Is IFN-beta Treatment in MS Useful After a Washout Period in Patients With Neutralizing Antibodies to Interferon Beta | View | |
| NCT01475409 | A Study on Changes in IFN-gamma Levels Following Anti-TNF Treatment in Patients Undergoing Serial QuantiFERON-TB Gold In-Tube | View | |
| NCT00504140 | Recombinant Interferon Alpha and Etoposide in Relapsed Osteosarcoma | View | |
| NCT00517569 | Gene Therapy With GX-12 in Combination With HAART for the HIV-1 Infected Patients | View | |
| NCT01482390 | A Study of Mericitabine in Combination With Telaprevir and Peginterferon Alfa-2a Ribavirin in Participants With Chronic Hepatitis C | View | |
| NCT01519960 | A Study of Pegasys Peginterferon Alfa-2a Versus Untreated Control in Children With HBeAg Positive Chronic Hepatitis B | View | |
| NCT01513941 | An Efficacy and Safety Study of Telaprevir in Patients Infected With Both Chronic Hepatitis C Virus HCV-1 and Human Immunodeficiency Virus HIV-1 | View | |
| NCT01529073 | Efficacy of Pegylated Interferon Plus Ribavirin Plus Nitazoxanide in HCV Genotype 4 and HIV Coinfection | View | |
| NCT00595907 | Results of an Interferon-Gamma Release Assay After Treatment for Tuberculosis | View | |
| NCT00621439 | Investigative Trial of Interferon Alpha-2b To Shrink Cancer of the Eye | View | |
| NCT01542788 | Sofosbuvir Ribavirin for 12 Weeks in Subjects With Chronic Genotype 2 or 3 Hepatitis C Infection Who Are Interferon Intolerant Interferon Ineligible or Unwilling to Take Interferon | View | |
| NCT00630721 | Characterization of Interferon Beta -1b-Induced Tolerizing Effect in Dendritic Cells | View | |
| NCT02519556 | Trial on Effectiveness Combined Probiotics in Atopic Dermatitis in Children | View | |
| NCT04522557 | Type I Interferon Alfa-2a in Postmastectomy Breast Reconstruction | View | |
| NCT01561664 | Inflammation Regulation in Obese Patients | View | |
| NCT00682591 | Evaluation of Neurocognitive Performance in Drug Substituted Patients Under Hepatitis C Therapy | View | |
| NCT00684242 | Lenalidomide Revlimid for the Treatment of Refractory Cancer Pain | View | |
| NCT00686777 | Pegylated Interferon PEG-IFN Alfa-2b and Low Dose Ribavirin for the Treatment of Chronic Hepatitis C Patients With Genotype 1 High Viral Load and Low Body Weight Study P05172COMPLETED | View | |
| NCT00686517 | Evaluation of Peginterferon Alfa-2b Monotherapy and Combination With Ribavirin in Participants With Acute Hepatitis C P03552MK-4031-137 | View | |
| NCT00684268 | Intravenous Silibinin in Combination With Peg-interferon and Ribavirin in Nonresponders | View | |
| NCT00687999 | NIDDM and IR in Combination Therapy for CHC | View | |
| NCT01571583 | An Efficacy and Safety Study of Telaprevir in Patients With Genotype 1 Hepatitis C Infection After Liver Transplantation | View | |
| NCT01962441 | SOF Sovaldi RBV for 16 or 24 Weeks and SOFRBVPeg-IFN for 12 Weeks in Adults With Genotype 2 or 3 Chronic HCV Infection | View | |
| NCT01589952 | Pegylated Interferon and Entecavir Combination in Chronic Hepatitis B CHB | View | |
| NCT00723645 | Rate and Predictors of Relapse in the Treatment of Hepatitis C Study P05181 | View | |
| NCT00725842 | Relapse Rate in Hepatitis C Patients Treated With Peginterferon Alfa-2b Plus Ribavirin in Common Clinical Practice in France P05484Completed | View | |
| NCT00724776 | Albinterferon Alfa 2b Single Dose in Japanese Chronic Hepatitis C Patients | View | |
| NCT00537407 | A Study of Debio 025 in Combination With PegIFN Alpha-2a and Ribavirin in Chronic HCV Patients Non-responders to Standard Treatment | View | |
| NCT00736242 | Post-marketing Surveillance of HIV-infected Patients With Chronic Hepatitis C Treated With PegIntron Pen and Rebetol Study P04584 | View | |
| NCT01592474 | Evaluation of Brain Atrophy in CIS Patients on Avonex | View | |
| NCT00761735 | 5 Year Long-term Follow up in Pediatric Participants Who Received PegIntron Plus Rebetol in P02538 Part I P02538 Pt 2 | View | |
| NCT01606800 | Efficacy and Safety of Short Course Therapy With Peginterferon Alpha-2b PEG-IFN Alfa-2b and Ribavirin RBV for Chronic Hepatitis C Genotype 4 Participants Achieving a Rapid Virological Response at Week 4 of Treatment MK-8908B-059 | View | |
| NCT02609659 | OmbitasvirParitaprevirRitonavir and Dasabuvir With Low-Dose Ribavirin QD in Subjects With Genotype 1a Chronic Hepatitis C Virus Infection | View | |
| NCT00780910 | Efficacy and Safety of MP-424 Peginterferon Alfa-2b and Ribavirin in Patients With Chronic Hepatitis C Who Relapsed After Previous Interferon Based Therapy | View | |
| NCT00786643 | Study of Gamma Interfereon in Metastatic Colorectal Carcinoma | View | |
| NCT01622933 | Multiple Antigen-Engineered DC Vaccine for Melanoma | View | |
| NCT00811395 | Long Term Safety of Teriflunomide When Added to Interferon-Beta or Glatiramer Acetate in Patients With Multiple Sclerosis | View | |
| NCT01620502 | N-3 Polyunsaturated Fatty Acids in the Prevention and Treatment for IFN-induced Depression | View | |
| NCT01625793 | Inflammation Stress Social Behavior Using Ecological Assessments Model Systems to Enhance Relevance to Health Outcomes | View | |
| NCT02193022 | Miltefosine for Children With PKDL | View | |
| NCT01639261 | A Phase II Trial on Treatment of Steroid-refractory Bronchiolitis Obliterans With Interferon Gamma 1b After Allogeneic SCT | View | |
| NCT01636778 | Japanese Phase II Study of SB-497115-GR in Hepatitis C Virus Infected Patients | View | |
| NCT00866021 | Treatment of HIVHCV Coinfection With Peg-IFN and Ribavirin in Patients Receiving ART Monotherapy With Lopinavirr | View | |
| NCT01641094 | Effect of Teleprevir in Triple Therapy on Intrahepatic Immunological Mechanisms | View | |
| NCT02339337 | A Pilot Study To Evaluate the Efficacy of Response Guided Therapy of Peginterferon Alfa Plus Ribavirin in the Treatment of Patients With HCVHBV Co-Infection | View | |
| NCT02446717 | A Study to Evaluate the Efficacy Safety and Pharmacokinetics of ABT-493 and ABT-530 With and Without Ribavirin in Adults With HCV Who Failed a Prior DAA Containing Therapy | View | |
| NCT00883844 | PEG-IFN in HBV Patients With Incomplete Response to NA | View | |
| NCT00687544 | Efficacy and Safety of PegIntron Plus Ribavirin for Treatment of Chronic Hepatitis C in HIV-Infected Subjects Study P04469TERMINATED | View | |
| NCT00895882 | Study to Evaluate Different Regimens of Vaniprevir MK7009 for the Treatment of Chronic Genotype 1 Hepatitis C Virus Infection in Treatment-naive Patients MK-7009-019WITHDRAWN | View | |
| NCT01657604 | TKI and Interferon Alpha Evaluation Initiated by the German Chronic Myeloid Leukemia Study Group - the TIGER Study | View | |
| NCT00905632 | 4 Week Combination of BI 207127 NA With Peg-IFN and Ribavirin in Chronic HCV Patients | View | |
| NCT00927082 | A Follow-Up Study to WV19432 to Evaluate Long Term Post-Treatment Effects of PEGASYS Peginterferon Alfa-2a40KDin Patients With HBeAg Positive Chronic Hepatitis B | View | |
| NCT00956982 | PEG-IFN Plus Ribavirin Combination Therapy for Older Patients | View | |
| NCT01668381 | Enumeration and Function Analysis of Treg Cells in Peripheral Blood of HCC Patients Before and After Ablation Therapy | View | |
| NCT01664845 | Effects of Metformin Pegylated Interferon Alpha and Ribavirin for Chronic Hepatitis C With Insulin Resistance | View | |
| NCT01678131 | Evaluating Fine Needle Aspiration to Measure Hepatic Vaniprevir MK-7009 Concentrations in Participants With Chronic Hepatitis C MK-7009-048 | View | |
| NCT04647695 | IFN-beta 1b and Remdesivir for COVID19 | View | |
| NCT01670994 | QUILT-3020 A Study of ALT-801 in Patients With Relapsed or Refractory Multiple Myeloma | View | |
| NCT01007058 | Markers of Response to Intravesical Bladder Cancer Therapy | View | |
| NCT01033981 | Cost Effectiveness Of Sunitinib In Central America And Caribbean | View | |
| NCT01031199 | Evaluation of the Positron Emission Tomography PET Tracer ZK 6032924 in Patients With Multiple Sclerosis Compared to Healthy Volunteers | View | |
| NCT01034579 | The REbif vs Glatiramer Acetate in Relapsing Multiple Sclerosis Pharmacogenetics Trial | View | |
| NCT01058343 | Safety of IFNa Kinoid in Systemic Lupus Erythematosus | View | |
| NCT02244372 | Efficacy and Safety of Cordyceps Sinensis Mycelium Culture ExtractPaecilomyces Hepiali CBG-CS-2 on Promotion of Immunity | View | |
| NCT01074593 | Pharmacokinetics and Pharmacodynamics of the Interferon Beta-1a Produced by Laboratorio Quimico Farmaceutico Bergamo Compared to Interferon Beta-1a Rebif - Merck Serono in Healthy Subjects | View | |
| NCT02250807 | Efficacy and Safety Study of Simeprevir in Combination With Sofosbuvir in Subjects With Chronic Genotype 4 Hepatitis C Virus Infection | View | |
| NCT01706575 | A Study of Pegasys Peginterferon Alfa-2a Added to NucleostIde Analogue Treatment in Participants With HBeAg-Negative Chronic Hepatitis B Genotype D Showing Stable Hepatitis B Virus HBV Deoxyribonucleic Acid DNA Suppression | View | |
| NCT01212367 | Intrapleural Gene Transfer for Pleural Mesothelioma | View | |
| NCT01095835 | A Study of Pegylated Interferon Alfa-2a and Lamivudine in Patients With HBeAg-Negative Chronic Hepatitis B Virus HBV | View | |
| NCT01718834 | Safety and Efficacy Study of CENV3 Vaccine to Protect Against HCV Infection | View | |
| NCT01134627 | Minocycline as add-on to Interferon Beta-1a IFN Beta-1a Rebif in Relapsing-Remitting Multiple Sclerosis RRMS | View | |
| NCT01718145 | A Phase 3 Comparative Study of Asunaprevir and Daclatasvir Combination Therapy Versus Telaprevir Therapy in Japanese HCV Subjects | View | |
| NCT02331706 | IFN-DLI for Relapsed Acute Leukemia After Allo-SCT | View | |
| NCT01162785 | 1B Intravesical Administration of SCH 721015 Ad-IFNa in Admixture With SCH 209702 Syn3 for The Treatment of BCG Refractory Superficial Bladder Cancer | View | |
| NCT01514890 | French Cohort of Therapeutic Failure and Resistances in Patients Treated With a Protease Inhibitor Telaprevir or Boceprevir Pegylated Interferon and Ribavirin | View | |
| NCT04732832 | HCV Reinfection in HD Patients Achieving SVR | View | |
| NCT02761629 | Efficacy and Safety of Peg-Interferon Alpha-2a Plus Ribavirin in Genotype 1 Chronic Hepatitis C Participants Co-Infected With Human Immunodeficiency Virus | View | |
| NCT01207648 | Retrospective Cohort Study of Rebif Use in Pediatric Multiple Sclerosis MS Subjects REPLAY | View | |
| NCT02155322 | A Phase II Study of Pegylated Interferon Alfa-2b for the Adjuvant Treatment of Melanoma Subjects in Russia MK-4031-400 | View | |
| NCT04751643 | Therapeutic Plasma Exchange to Alleviate Hyperinflammatory Condition During Severe Covid-19 Infections | View | |
| NCT01500616 | Telaprevir Open-Label Study in Co-Infected Patients | View | |
| NCT01288209 | A Phase III Study of TMC435 in Genotype 1 Hepatitis C-infected Participants Who Failed to Respond to Previous IFN-based Therapy | View | |
| NCT01317017 | Cell Responses to IFN-gamma | View | |
| NCT01342003 | HCV Genotype 1a Shows a Better Virological Response to Antiviral Therapy Than HCV Genotype 1b | View | |
| NCT01770223 | A Study of Viral Response to Triple Therapy in Hepatitis C Virus-Infected Participants With Insulin Resistance Who Failed Dual Therapy MK-3034-113 | View | |
| NCT01373684 | PEG-interferon Alfa-2a add-on Study in HBeAg Negative Chronic Hepatitis B Patients | View | |
| NCT01376362 | Topical Interferon Gamma for Macular Edema Secondary to Uveitis | View | |
| NCT01392729 | An Observational Study of Avastin Bevacizumab and Interferon Alpha 2a in Patients With Metastatic Renal Cell Cancer VERA | View | |
| NCT01409187 | IPI-Biotherapy for Patients Previously Treated With Cytotoxic Drugs With Metastatic Melanoma | View | |
| NCT01425970 | Chronically-infected HCV Genotype 2 and 3 Treatment-naive Subjects Part A Safety and Efficacy of INX-08189 With Peg IFN Alfa-2a and Ribavirin Part B INX-08189 in Interferon Free Treatment With Daclatasvir andor Ribavirin | View | |
| NCT02469012 | Neurocognitive Performance and Emotional State in HCV Patients With IFN-free Antiviral Therapy | View | |
| NCT01459913 | Efficacy of a 12-Week Regimen of Telaprevir Pegylated Interferon and Ribavirin in Treatment-Naive and Prior Relapser Subjects With Interleukin28B IL28B CC Genotype | View | |
| NCT01459562 | First in Human Study of an Anti-IFN Gamma Monoclonal Antibody in Healthy Volunteers | View | |
| NCT01462773 | Study of Patients With Stage IV Malignant Melanoma Using PS-341 Bortezomib Velcade and Interferon-alpha-2b in Malignant Melanoma | View | |
| NCT01460875 | Recombinant Interferon Alfa-2b in Treating Patients With Melanoma | View | |
| NCT01482767 | Evaluating the Effectiveness of Boceprevir Pegylated-Interferon Alfa 2b and Ribavirin in Treating Hepatitis C Virus HCV Infection in Adults With HIV and HCV Infection | View | |
| NCT02485080 | Safety Tolerability and Efficacy of 24 Weeks SimeprevirSofosbuvir for Chronic Hepatitis C Genotype 1 | View | |
| NCT03027154 | Clinical Study of Recombinant Mycobacterium Tuberculosis ESAT6-CFP10 Allergen for Children | View | |
| NCT00489489 | Phase II Study of Teriflunomide as Adjunctive Therapy to Interferon-beta in Subjects With Multiple Sclerosis | View | |
| NCT03123653 | To Study the Efficacy of PEG-IFN Alpha in HBeAg Negative Chronic Hepatitis B Patients After Stopping Nucleotide Analogue Therapy | View | |
| NCT01556685 | MATRIX Measuring Neutralizing Antibodies in the Patients Treated With Interferon Beta 1a IM in Mexico and Colombia | View | |
| NCT01584687 | mRNA Expression as a Biomarker of Omalizumab Response | View | |
| NCT04966052 | COPD Co-infection With Tuberculosis on Th17 Cell Differentiation | View | |
| NCT01605513 | Safety Study of Recombinant Interferon VariantPEG-IFN-SA to Treat HCV Disease | View | |
| NCT01608594 | Neoadjuvant Combination Therapy With Ipilimumab and HighDose IFN-α2b for Melanoma | View | |
| NCT04979091 | Sex Hormone Dysregulations Are Associated With Critical Illness in COVID-19 Patients | View | |
| NCT01628744 | Autoantibodies Against Specific Cytokines in Adults With Severe Mycobacterial Infection | View | |
| NCT03103555 | Treatment of Adult-Onset Immunodeficiency With Bortezomib | View | |
| NCT01625338 | Open-Label Study of SofusbuvirRibavirin With or Without Peginterferon Alfa-2a in Subjects With Chronic HCV Infection Who Participated in Prior Gilead HCV Studies | View | |
| NCT01649921 | The Effects of Interferon-gamma on Sepsis-induced Immunoparalysis | View | |
| NCT02969668 | Interferon-free Antiviral Treatment of Chronic Hepatitis C Virus Infection Among Opioid-substituted Patients | View | |
| NCT01687244 | Intravesical Administration of rAd-IFNSyn3 in Patients With BCG-Refractory or Relapsed Bladder Cancer | View | |
| NCT02980198 | Study of IFN-K in Dermatomyositis | View | |
| NCT01709474 | Vitamin D3 Treatment in Pediatric Systemic Lupus Erythematosus | View | |
| NCT05054114 | Study of the Use of Nasal IFN-γ in Patients for the Prevention of Acute Respiratory Viral Infections Icluding COVID-19 | View | |
| NCT05076760 | MEM-288 Oncolytic Virus Alone and in Combination With Nivolumab in Solid Tumors Including Non-Small Cell Lung Cancer | View | |
| NCT02430194 | Lonafarnib Boosted With Ritonavir With and Without Peginterferon Alfa-2a PEG IFN-a in HDV LOWR-2 | View | |
| NCT01732796 | IFN-free Combination Therapy in HCV-infected Patients Treatment-naiveHCVerso1 | View | |
| NCT01736787 | Efficacy and Safety of Cauliflower Mushroom Extract on Promotion of Immunity | View | |
| NCT01743521 | DAA Based Therapy for Recently Acquired Hepatitis C DARE-C | View | |
| NCT01753557 | Efficacy and Safety of MP-424 Peginterferon Alfa-2a PEG-IFN Alfa-2a and RibavirinRBV in Treatment-Naïve or Relapsed Hepatitis C | View | |
| NCT01753570 | Efficacy and Safety of MP-424 Interferon Beta IFN Beta and RibavirinRBV in Treatment-Naïve or Having Received Interferon Based Therapy With Chronic Hepatitis C CHC | View | |
| NCT01773889 | A Trial of Intravenous Denileukin Diftitox Plus Subcutaneous Pegylated IFNα-2A in Stage III or IV Ovarian Cancer | View | |
| NCT05107778 | Study to Evaluate Safety and Efficacy of ASC42 Combined With ETV and PEG-IFN α-2a in Subjects With HBV | View | |
| NCT03090035 | Impact of Interleukin 28B rs12979860 Genotype on Virological Responses Chronic Hepatitis C Treatment | View | |
| NCT01258101 | A Study of PEGASYS Peginterferon Alfa-2a Plus Ribavirin in Patients With Chronic Hepatitis C CHC Genotype 2 or 3 | View | |
| NCT03020004 | Efficacy and Safety of Danoprevirr PR 12-week Triple Therapy in Treatment-Naive Non-Cirrhotic G1 CHC China II | View | |
| NCT03020082 | Efficacy and Safety of Danoprevirr PR 12week Triple Therapy in Treatment Naive Non-Cirrhotic G1 CHC China III | View | |
| NCT01935817 | Silybin - Vitamin E- Phospholipids Complex Reduces Liver Fibrosis in Patients With Chronic Hepatitis C Treated With Peg-IFN-a and RBV | View | |
| NCT01935635 | A Clinical Trial on HB-Vac Activated-DCs Combined With Peg-IFN or NAs in CHB | View | |
| NCT01971346 | The Immunological Basis for Treatment Resistance to Anti-TNF Treatments | View | |
| NCT01995266 | Phase III China GT 1b Interferon IFN Intolerant Prev Exclude Dual | View | |
| NCT01997203 | Long Term Vitamin D Therapy in HCV Treated Patients | View | |
| NCT02008864 | Evaluating the Effect of Senna in Uremic Pruritus | View | |
| NCT02023112 | Study to Evaluate the Efficacy and Safety of ABT-450RitonavirABT- 267 ABT-450rABT-267 in Japanese Adults With Genotype 2 Chronic Hepatitis C Virus HCV Infection | View | |
| NCT03210467 | The Changes of Plasmacytoid Dendritic Cells Frequency and Function During Antiviral Therapy | View | |
| NCT03210493 | The Changes of Treg Cells Frequency and Function During Antiviral Therapy | View | |
| NCT03210506 | The Changes of Cytokines During Antiviral Therapy | View | |
| NCT00557765 | Use of a Gamma-IFN Assay in Contact Tracing for Tuberculosis in a Low-Incidence High Immigration Area | View | |
| NCT03370627 | Effect of Anti-CD303 Antibodies in Autoimmune Diseases | View | |
| NCT02057887 | SafetyTolerability and Pharmacokinetic Study of Recombinant Human Interferon Alfa 2B in Chronic Hepatitis C Patients HM10660A | View | |
| NCT03222583 | A Study to Evaluate the Efficacy and Safety of GlecaprevirPibrentasvir ABT-493ABT-530 in Treatment-Naive and Treatment-Experienced Non-Cirrhotic Asian Adults With Chronic Hepatitis C Virus Genotype GT 1 to GT6 Infection With or Without Human Immunodeficiency Virus Co-Infection | View | |
| NCT05347992 | ELEVATE - Empower Lupus Erythematosus Patients Via Allowing RemoTe Evaluation | View | |
| NCT02089685 | Safety and Tolerability of Pembrolizumab MK-3475 Pegylated Interferon Alfa-2b and Pembrolizumab Ipilimumab in Participants With Advanced Melanoma or Renal Cell Carcinoma MK-3475-029KEYNOTE-29 | View | |
| NCT02097849 | Vaccination Response in Tecfidera-Treated Versus Interferon-Treated Participants With Relapsing Forms of Multiple Sclerosis | View | |
| NCT02515695 | Phase I BP Interferon IFN Beta-001 | View | |
| NCT02112630 | Boceprevir in End Stage Renal Disease ESRD | View | |
| NCT02112032 | Treatment of Advanced Melanoma With MK-3475 and Peginterferon | View | |
| NCT02125578 | A Multiple Dose Safety Study of PEG-IFN in Healthy Volunteers | View | |
| NCT05378646 | Efficiency and Safety of the Drug Ingaron Interferon-gamma Human Recombinant in the Treatment of Chronic Prostatitis | View | |
| NCT05398965 | Eucalyptus Oil as Adjuvant Therapy for Coronavirus Disease 19 COVID-19 | View | |
| NCT01220648 | Determining the Maximum Tolerated Dose of Low Dose Interferon-alpha in Conjunction With Nilotinib in Pretreated Philadelphia Chromosome Positive Ph Chronic Myeloid Leukemia Patients in Chronic Phase CML-CP | View | |
| NCT02194998 | Evaluating the Safety and Effectiveness of Interferon-Free Treatment of Hepatitis C Virus Infection in HIV-Coinfected Adults on Antiretroviral Therapy | View | |
| NCT02234869 | Transition to Peginterferon Beta-1a BIIB017 From Subcutaneous Interferon Therapy | View | |
| NCT03420300 | EBRGZR for HCV-1b Patients Receiving Hemodialysis | View | |
| NCT03422120 | Human Blood Specimen Collection to Evaluate Immune Cell Function | View | |
| NCT00287079 | A Prospective Study Looking at the Use of Rebif in Subjects With Clinically Isolated Syndrome | View | |
| NCT05491304 | Cytokine Guided Risk Stratification and Treatment in Pediatric Hemophagocytic Lymphohistiocytosis | View | |
| NCT00565539 | Study of PEG-rIL-29 or PEG-IFN Lambda in Subjects With Chronic Hepatitis C Virus Infection | View | |
| NCT02339324 | Neoadjuvant Combination Biotherapy With Pembrolizumab and High Dose IFN-alfa2b | View | |
| NCT05539118 | Interferon-α1b Combined With Toripalimab and Anlotinib Hydrochloride in Advanced Unresectable Melanoma | View | |
| NCT02389335 | Roles of T Helper 1 Cytokines in Type 1 Diabetes | View | |
| NCT05558345 | Expression of Stress Markers During Meth Treatment EXPRESS | View | |
| NCT02419638 | Comparison of Rebif Compared to Tecifdera on Six-month Outcomes in Patients With Relapsing-remitting MS | View | |
| NCT02447887 | Study of Ixazomib With Pegylated IFN-alpha 2b pIFN in Metastatic Renal Cell Carcinoma mRCC | View | |
| NCT05622916 | Topical Ethanol Extract Piper Crocatum for Anogenital Warts | View | |
| NCT02487199 | OmbitasvirParitaprevirRitonavir With or Without Dasabuvir in Adults With Genotype 1a or Genotype 4 Chronic Hepatitis C Virus HCV Infection With Severe Kidney Impairment or End Stage Kidney Disease | View | |
| NCT01517308 | 24 VS 48-WEEK TREATMENT WITH PEG-IFN ALPHA-2A IN PATIENTS WITH GENOTYPE 23 CHRONIC HEPATITIS C | View | |
| NCT02517528 | ABT-450Ritonavir ABT-267 ABT-450rABT-267 and ABT-333 Co-Administered With Ribavirin RBV in Treatment Naïve and Treatment Experienced Asian Adults With Genotype 1b Chronic Hepatitis C Virus HCV Infection and Compensated Cirrhosis | View | |
| NCT02517788 | Phase I BP Interferon IFN Beta-004 | View | |
| NCT02577029 | Study of ARC-520 With or Without Other Drugs Used in the Treatment of Chronic Chronic Hepatitis B Virus HBV | View | |
| NCT02860611 | Comparison of Th1 Cytokine Levels Between Type 1 and Type 2 Diabetes | View | |
| NCT02609932 | Effect of IFN-γ on Innate Immune Cells | View | |
| NCT02604017 | A Study to Evaluate the Efficacy and Safety of ABT-493ABT-530 in Subjects With Genotype 1 Infection | View | |
| NCT02614456 | Combination of Interferon-gamma and Nivolumab for Advanced Solid Tumors | View | |
| NCT02661685 | Safety Study of Adoptive Transfer of Autologous IKDC-like Cells | View | |
| NCT05721300 | Study on Screening Verification and Intervention of High-risk Patients With Liver Cancer | View | |
| NCT02665364 | Phase IIb Study of IFN-K in Systemic Lupus Erythematosus | View | |
| NCT00522249 | Study of Pegylated Alfa Interferon Sunitinib and Tarceva in Patients With Metastatic RCC | View | |
| NCT05724212 | Evaluation of a CD4CD8 Interferon Gamma Release Assay for Monitoring Anti-Tuberculosis Treatment | View | |
| NCT03623763 | Vitamin D Level Among Athletes in Uzbekistan | View | |
| NCT02692976 | Natural Dendritic Cells for Immunotherapy of Chemo-naive Metastatic Castration-resistant Prostate Cancer Patients | View | |
| NCT02732639 | A Study of Pegylated Interferon PEG-IFN Alfa-2a Pegasys in Participants With Chronic Hepatitis D CHD | View | |
| NCT02742324 | Trial Ruxolitinib and Peg-interferon Alpha-2a Combination in Patients With Primary Myelofibrosis RUXOPeg | View | |
| NCT05795257 | Pulmonary Immune Cell-microbiome Interactions in ARDS | View | |
| NCT02794636 | Interferon Toxicities in Melanoma Treatment | View | |
| NCT02838342 | Pharmaco-immunological Study of Interferon-alpha and Metronomic Cyclophosphamide Association in Neuroendocrine Tumors | View | |
| NCT02851576 | Clinical Grade Adenovirus Specific T Cells for Immunotherapy After Allogeneic Stem Cell Transplantation CTL-ADV | View | |
| NCT01830673 | Regulatory T-cells After Subcutaneous Immunotherapy | View | |
| NCT04285086 | Ropeginterferon Alfa-2b P1101 vs Anagrelide in Essential Thrombocythemia Patients With Hydroxyurea Resistance or Intolerance | View | |
| NCT02876419 | A Long Term Follow-up Study of Patients From the REP 301 Protocol | View | |
| NCT04293887 | Efficacy and Safety of IFN-α2β in the Treatment of Novel Coronavirus Patients | View | |
| NCT05443516 | Disease Activity Biomarkers in Patients With Systemic Lupus Erythematosus | View | |
| NCT05914935 | Safety and Tolerability Study of Recombinant L-IFN Adenovirus Injection in Patients With Recurrent Glioblastoma | View | |
| NCT02966795 | A Study of of GlecaprevirPibrentasvir in Adults With Chronic Hepatitis C Virus HCV Genotype 5 or 6 Infection | View | |
| NCT03017820 | VSV-hIFNbeta-NIS in Treating Patients With Relapsed or Refractory Multiple Myeloma Acute Myeloid Leukemia or Lymphoma | View | |
| NCT03026972 | A Phase ⅠStudy of the Recombinant Mycobacterium Tuberculosis Vaccine Freeze-dried | View | |
| NCT03067129 | A Study to Evaluate the Pharmacokinetics Safety and Efficacy of GlecaprevirPibrentasvir in Pediatric Subjects With Genotypes 1-6 Chronic Hepatitis C Virus HCV Infection | View | |
| NCT03069365 | A Study to Evaluate the Efficacy and Safety of GlecaprevirPibrentasvir in Adults With Chronic Hepatitis C Virus Genotype 1 - 6 Infection and Renal Impairment | View | |
| NCT04590261 | Myeloid Cells in Patients With Covid-19 Pneumonia | View | |
| NCT03125213 | A Study Evaluating AL-3778 in Combination With Peginterferon Alpha-2a in Chronic Hepatitis B Subjects | View | |
| NCT03136939 | Study of IGRP-specific T Cell in Peripheral Blood of Type 1 Diabetes Mellitus | View | |
| NCT03177083 | Evaluate SafetyTolerability in Portuguese Participants With RRMS Transitioning From Current Therapy | View | |
| NCT05446428 | Evaluation of Type I IFN Level and Disease Activity in SLE Patients | View | |
| NCT01064401 | Efficacy and Safety of BIIB019 Daclizumab High Yield Process Versus Interferon β 1a in Participants With Relapsing-Remitting Multiple Sclerosis | View | |
| NCT03209037 | The Changes of CD8T Cells Frequency and Function During Antiviral Therapy | View | |
| NCT03206359 | GADD34 and Type I IFN Response Genes in SLE | View | |
| NCT03209219 | Interferon α2a Versus Cyclosporine for Refractory Behçets Disease Uveitis | View | |
| NCT02387463 | Efficacy of Extended Peginterferon Alpha 2a Treatment in HBeAg Positive Chronic Hepatitis B Patients | View | |
| NCT05536219 | Impact of the Presence of Anti-interferon Autoantibodies on the Viral Load in Severe Respiratory Infections | View | |
| NCT03244943 | Cytokine Profiles in Breast Cancer Patients Undergoing Chemotherapy | View | |
| NCT03315858 | NFAT-regulated Gene Expression After Tacrolimus | View | |
| NCT06130579 | Interferon-α for TP53 Myeloid Malignancy Post Allo-HSCT | View | |
| NCT02387684 | Efficay of Extended Peginterferon Alpha 2a Treatment in HBeAg Negative Chronic Hepatitis B Patients | View | |
| NCT03387046 | A Pilot Study in Participants With Relapsing Remitting Multiple Sclerosis RR-MS | View | |
| NCT04628338 | IFN-γ to Treat Acute Myeloid Leukemia AML and Myelodysplastic Syndrome MDS That Has Relapsed After Allogeneic Hematopoietic Stem Cell Transplantation | View | |
| NCT03416543 | Effect of a New BI-specifiC Antibody Towards Dendritic Cells on Inflammation in Rheumatoid Arthritis | View | |
| NCT03435601 | A Study to Target the Type I IFN Receptor by Administrating Anifrolumab in RA Patients With a High IFN Signature TarIFNiRA | View | |
| NCT03435302 | HDI Versus Chemotherapy as Systemic Adjuvant Therapy for Resected Mucosal Melanoma | View | |
| NCT06196632 | Development and Validation of Models to Predict Functional Cure in Patients With CHB After Peg-IFN Based Therapy | View | |
| NCT04648709 | Evaluation and Longitudinal Follow-up of Biomarkers Predictive of Severe Forms of COVID-19 | View | |
| NCT04810585 | Plasma Biomarker for Aflibercept in Advanced Colorectal Cancer | View | |
| NCT03488771 | Evaluation of Cell-mediated Immune Response by QuantiFERON Monitor Assay in Kidney Transplant Recipients | View | |
| NCT06222801 | The 1st Tumor CytokinoTherapy Database TCTD-1 | View | |
| NCT03548818 | Role of Interferon-gamma 1-b IFN-γ on Cells of the Innate Immune System Functional Biochemical and Gene Expression Studies in Patients With Chronic Granulomatous Disease | View | |
| NCT04691765 | Anakinra in Previously Untreated Chronic Lymphocytic Leukemia Patients | View | |
| NCT04722029 | Pilot Study of Haploidentical Donor Adenovirus Specific T-lymphocytes to Treat Refractory Adenovirus Infections | View | |
| NCT04860518 | Human Intravenous Interferon Beta-Ia Safety and Preliminary Efficacy in Hospitalized Subjects With COVID-19 | View | |
| NCT06354205 | Comparison of Salivary Procalcitonin PCT Levels and Serum PCT Levels | View | |
| NCT05290688 | Cellular microRNA Signatures in Multiple Sclerosis | View | |
| NCT03761966 | Cytokines Profile at the Beginning of Pregnancy | View | |
| NCT05180851 | Safety and Efficacy of Recombinant Oncolytic Adenovirus L-IFN Injection in RelapsedRefractory Solid Tumors Clinical Study | View | |
| NCT04952207 | Effectiveness and Safety of Direct-Acting Antiviral Agents for the Treatment of Chronic Hepatitis C | View | |
| NCT06448052 | Umbilical Cord Mesenchymal Stem Cell for Aging-related Low-grade Inflammation | View | |
| NCT04963712 | Zadaxin and HIV-positive Patients With Immune Reconstitution Disorder | View | |
| NCT04565262 | Study on Antiviral Therapy for HBeAg-positive Chronic Hepatitis B Patients Aged 1-16 Years | View | |
| NCT06488937 | Biomarkers Associated With Temporomandibular Disorders in Patients With Rheumatoid Arthritis | View | |
| NCT01855997 | A Study to Collect Blood Biomarker Samples From Participants With Chronic Hepatitis B CHB Who Received Treatment With Pegasys Peginterferon Alfa-2a NucleosideNucleotide Analogue | View | |
| NCT05002062 | Efficacy of Cognitive Behavioral Therapy on Fatigue Cognition and Inflammatory Biomarkers in MS Patients | View | |
| NCT06529731 | Interferon-γ IFN-γ With Donor Leukocyte Infusion to Treat Relapsed Acute Myeloid Leukemia and Myelodysplastic Syndromes Post Allogeneic Hematopoietic Stem Cell Transplantation | View | |
| NCT05028634 | Safety Study to Evaluate Immune Response of Vaccines in Participants With Relapsing Forms of Multiple Sclerosis Who Receive Ozanimod Compared to Non-Pegylated Interferon IFN-β or No Disease Modifying Therapy | View | |
| NCT04079088 | Study to Evaluate Oral BIIB061 Added to Interferon-beta1 IFN-β1 or Glatiramer Acetate in Relapsing Multiple Sclerosis RMS | View | |
| NCT04088019 | Proportion of Clinical Improvement Type 1 Interferon IFN Score Changes in Idiopathic Uveitis Patients With Interferon Gamma Release Assay IGRA Positive | View | |
| NCT06558305 | IL-6 IL-12 IL-15 and IL-23 Expression Levels in Rheumatoid Arthritis Patients | View | |
| NCT04120818 | Inflammatory Cytokines in Congenital Cataract After Lensectomy and Anterior Vitrectomy | View | |
| NCT05490836 | Functional Cure Rate of Peg-IFNα-2b Combined With TAF in HBeAg Negative CHB Patients | View | |
| NCT05065905 | Study of Interferon-Gamma in the Complex Treatment of Patients Infected With HIV and Tuberculosis | View | |
| NCT04189627 | A Study of the Effectiveness and Clinical Practice Use of GlecaprevirPibrentasvir in Adolescents With Chronic Hepatitis C Genotypes 1 to 6 in Russian Federation | View | |
| NCT04206033 | Hemophilia and Bone Metabolism Study of Monocytic Populations and Inflammatory Proteins | View | |
| NCT04224597 | Evaluation of the Presence of Enthesitis in Patients With Acne Vulgaris | View | |
| NCT04246372 | Tofacitinib for Immune Skin Conditions in Down Syndrome | View | |
| NCT04266860 | Establishing Clinical Utility of a New Diagnostic Test for Rheumatology Patients | View | |
| NCT04276688 | Lopinavir Ritonavir Ribavirin and IFN-beta Combination for nCoV Treatment | View | |
| NCT04328714 | Interferon γ-Primed Mesenchymal Stromal Cells as Prophylaxis for Acute Graft v Host Disease | View | |
| NCT05891964 | Outcome of Treatment With Secukinumab in the Treatment of Moderate to Severe Plaque Psoriasis at Tertiary Care Hospital | View | |
| NCT04365933 | A Study of the Oral Farnesoid X Receptor Modulator EYP001a to Assess Its Safety and Anti-viral Effect in Chronic Hepatitis B Patients in Combination With Pegylated Interferon alpha2a Alone and With Entecavir | View | |
| NCT04379518 | Rintatolimod and IFN Alpha-2b for the Treatment of COVID-19 in Cancer Patients | View | |
| NCT05905185 | Interventional Strategy in Tackling Emerging Non-alcoholic Fatty Liver Disease in Childhood Obesity | View | |
| NCT02623556 | Clinical Study of Recombinant Mycobacterium Tuberculosis ESAT6-CFP10 Allergen | View | |
| NCT04469491 | Treatment of COVID-19 by Nebulization of Inteferon Beta 1b Efficiency and Safety Study | View | |
| NCT05922306 | Efficacy of NA Combined With PEG-IFN-α2b in the Continuous Versus Pulsed Treatment of Patients With Chronic Hepatitis B | View | |
| NCT00710021 | Vitamin D3 in Systemic Lupus Erythematosus | View | |
| NCT04494399 | IFN Beta-1b and Ribavirin for Covid-19 | View | |
| NCT04534634 | Study of IFN-α Combined With CAR-T Cell Therapy in Relapsed and Refractory Acute Lymphoblastic LeukemiaRR-ALL | View | |
| NCT02612480 | Ticagrelor in Human Endotoxemia Response to Human Endotoxemia | View | |
| NCT01863576 | Effects of Omega-3 Supplementation on the Cytokine and Lipid Profiles in Patients With Chronic Chagas Cardiomyopathy | View | |
| NCT05838599 | Combining Topical Imiquimod With Local Radiotherapy for Treatment of Mycosis Fungoides | View | |
| NCT04703114 | Study of the Immunological and Virological Response of Patients With COVID-19 and Presenting an Asymptomatic or Pauci-symptomatic Form AMBUCOV | View | |
| NCT05984394 | Evaluation of Antigen-specific T Cells in Patients With Antisynthetase Syndrome and Interstitial Lung Disease | View | |
| NCT04733105 | Pronostic Value of Type I ANTi-Interferon Antibodies in Patients With COVID-19 Acute Respiratory Failure | View | |
| NCT04864366 | Efficacy and Safety of TAF for 48 Weeks in HBeAg Positive CHB Patients | View | |
| NCT06235580 | Genotype-phenotype Characterization Study on Genetic Diseases With Immune and Neurological Dysfunctions | View | |
| NCT06100705 | Sipuleucel-T Combined With Bipolar Androgen Therapy in Men With mCRPC | View | |
| NCT04934111 | Safety and Immunogenicity of LNP-nCOV saRNA-02 Vaccine Against SARS-CoV-2 the Causative Agent of COVID-19 | View | |
| NCT04967430 | TOGETHER - Toronto Trial to Evaluate the Effect of Peginterferon Lambda for the Treatment of COVID-19 | View | |
| NCT06281353 | The Effect of Oral Nanocurcumin as an Adjuvant Therapy for Anogenital Warts Evaluation of Clinical Improvement NFĸB IFN-γ and FOXP3TReg From Lesions Tissue | View | |
| NCT05069610 | Evaluating Safety Tolerability and Potential Efficacy of Intranasal AD17002 in Adults With Mild to Moderate COVID-19 | View | |
| NCT02560649 | An Exploratory Study of RGT Strategy on Optimal NUC-experienced Patients | View | |
| NCT00043303 | Safety and Efficacy Study of Interferon Gamma-1b in Hepatitis C Patients With Liver Fibrosis or Cirrhosis | View | |
| NCT05156541 | Study of the Efficacy and Safety of the Drug Ingaron Interferon-gamma in the Treatment of Anogenital Warts | View | |
| NCT02363699 | Endovenous Lidocaine and Serum Cytokines Concentration | View | |
| NCT05244057 | A Study of Hepalatide Combined With TAF and PEG-IFN as Finite Treatment of Chronic Hepatitis B Patients | View | |
| NCT06371235 | Study of the Transmission of Anti-interferon Type 1 Alpha Autoantibodies From Mother to Child Via the Placental Barrier | View | |
| NCT06212388 | Allogeneic Gammadelta T Cells Combined With Interferon-α1b or PD-1 Monoclonal Antibody in Stage III-IV Amenable to Surgical Resection Melanoma | View | |
| NCT05268172 | IFN-γ Combined With T Cells in the Treatment of Refractory Malignant Pleural Effusion and Ascites | View | |
| NCT00630903 | PUVA Versus PUVA IFN Alpha 2a in Mycosis Fungoides | View | |
| NCT05283317 | Effect of Mesenchymal Stromal Cells on Sepsis and Septic Shock | View | |
| NCT00052039 | A Randomized Double-Blind Three-Arm Phase 3b Study Comparing the Safety and Efficacy of Interferon Gamma-1b With Azathioprine and Azathioprine Alone in Patients With IPF Receiving Prednisone | View | |
| NCT00273247 | Treatment With IFN After Curative Resection of HCC in HCV-Related Cirrhosis | View | |
| NCT01908335 | A Phase Ⅱ Dose-escalating Study of PEG-IFN-SA and Ribavirin in IFN Naive Patients With Chronic Hepatitis C | View | |
| NCT06549374 | Kinetics of INF-γ Production in Intensive Care Patients | View | |
| NCT06655831 | Key Mechanisms of Abnormal T Cell Activation and Differentiation in IgG4-Related Ophthalmic Disease | View | |
| NCT05395702 | Study of Ingarons Effect on Efficacy and Resistance to Antibiotics in Community-acquired Pneumonia | View | |
| NCT06430190 | Peginterferon α-2b Combined CO2 Laser in Condylomata Acuminata | View | |
| NCT01903278 | Efficacy and Safety Study of PEG-IFN-SA and Ribavirin to Treat Chronic Hepatitis C | View | |
| NCT01909557 | Acetyl-L-Carnitine Supplementation During HCV Therapy With Peg IFN-α2b Plus Ribavirin Effect on Work Performance | View | |
| NCT01911169 | Vitamin D to Improve Endothelial Function in SLE | View | |
| NCT06559670 | Prevention of Chronic Lung Disease CLD - Prevention Study | View | |
| NCT06508463 | Intravenous Vesicular Stomatitis Virus in Patients With Peripheral T-cell Lymphoma | View | |
| NCT00627926 | A Phase 3 Study of Telaprevir in Combination With Pegasys and Copegus in Treatment-Naive Subjects With Genotype 1 Hepatitis C Virus HCV | View | |
| NCT05478018 | Type 1 Interferon Induced Changes to Exercise Adaptations in Systemic Lupus Erythematosus Patients | View | |
| NCT00001035 | The Safety and Effectiveness of a Two-Drug Combination in the Treatment of Patients With Hepatitis C Plus Advanced HIV Infections | View | |
| NCT01935089 | Pilot Peg-Interferon-a2b in Decreasing Viral DNA in HIV | View | |
| NCT01939002 | Characterize Flu-like Symptoms in Relapsing Multiple Sclerosis Patients Transitioning From Non-Pegylated Interferon Beta IFN-β Therapies to Peginterferon Beta-1a BIIB017 | View | |
| NCT00149565 | Phase Ⅲ Randomized Trial in Postoperative Hepatocellular Carcinoma | View | |
| NCT01938781 | Optimized Treatment and Regression of HBV-induced Liver Fibrosis | View | |
| NCT05531747 | Replicative Stress in Hair Follicle Stem Cells and Pathogeny of Hidradenitis Suppurativa | View | |
| NCT06519357 | A Single-center Self-controlled Prospective Case Series Pilot Study to Assess the Effect of Lamivudine 3TC on Neurocognitive Impairment Biomarkers and Type-I IFN Interferon-Stimulated Genes in the Plasma of Patients With Mild Cognitive Impairment MCI | View | |
| NCT01957319 | Silybin Supplementation During HCV Therapy With Pegylated Interferon-α2b Plus Ribavirin Reduces Depression and Increases Work Ability | View | |
| NCT00055562 | Study to Compare the Efficacy and Safety of Two CC-5013 Dose Regimens in Subjects With Metastatic Malignant Melanoma | View | |
| NCT01952587 | X-linked Biological Response to HIV Sensing the ANRS EP 53 Study | View | |
| NCT01965327 | Interferon Gamma-1b in Friedreich Ataxia FRDA | View | |
| NCT00704405 | Safety and Efficacy of Vaniprevir MK-7009 With Pegylated Interferon Peg-IFN and Ribavirin RBV in Treatment-Experienced Hepatitis C Virus HCV Participants MK-7009-009 | View | |
| NCT00630058 | A Phase 1 Study of MP-424 Peginterferon Alfa 2b and Ribavirin in Hepatitis C | View | |
| NCT01973322 | Vaccination With Autologous Dendritic Cells Loaded With Autologous Tumor Lysate or Homogenate Combined With Immunomodulating Radiotherapy andor Preleukapheresis IFN-alfa in Patients With Metastatic Melanoma a Randomized Proof-of-principle Phase II Study | View | |
| NCT01986712 | A Study to Compare Quality of Life and Compliance in Patients Receiving High-dose Interferon Versus Pegylated Interferon in Patients With Surgically Resected Melanoma | View | |
| NCT00078442 | Safety and Tolerability of Pegylated Interferon PEG-IFN Alfa-2a in HIV Infected People | View | |
| NCT00758043 | A Study Evaluating 24-Week and 48-Week Telaprevir-Based Regimen in Treatment Naïve Subjects With Genotype 1 Chronic Hepatitis C Who Achieve an Extended Rapid Viral Response | View | |
| NCT00065468 | Study Evaluating Interferon And CCI-779 In Advanced Renal Cell Carcinoma | View | |
| NCT00066404 | Intrapleural BG00001 in Treating Patients With Malignant Pleural Mesothelioma or Malignant Pleural Effusions | View | |
| NCT02007356 | A Study to Assess Safety and Feasibility of Direct Infusions of Donor-derived Virus-specific T-cells in Recipients of Hematopoietic Stem Cell Transplantation With Post-transplant Viral Infections Using the Cytokine Capture System | View | |
| NCT02006745 | Open Label Trial of PEG-IFN RBV TVR vs PEG-IFN RBV Alone in Tx of HCV-1 in HIV-1 Co-infected Patients CHAT | View | |
| NCT02001818 | Pegylated Interferon Alfa-2b and Nilotinib for Augmentation of Complete Molecular Response in Chronic Myeloid Leukaemia | View | |
| NCT06586710 | Interferon Pathway Activation in Monogenic and Nonmonogenic Forms of Pediatric SLE | View | |
| NCT00819897 | Longitudinal Study in Clinically Isolated Syndrome CIS Patients Treated With Interferon Beta | View | |
| NCT00753467 | A Phase II Study to Determine the Safety and Efficacy of Interferon-gamma in Patients With Chronic Hepatitis B | View | |
| NCT06536413 | ATRA and Carfilzomib in Plasma Cell Myeloma Patients | View | |
| NCT02035020 | A Phase IIa Trial to Test Safety and Efficacy Interferon Gamma Treatment in Elevating Frataxin Levels in FRDA Patients | View | |
| NCT02047734 | Efficacy and Safety Study of Ozanimod in Relapsing Multiple Sclerosis | View | |
| NCT00943761 | A Study of Vaniprevir MK-7009 in Participants With Chronic Hepatitis C Infection After Participation in Other Vaniprevir Studies MK-7009-028 | View | |
| NCT05879718 | A Study to Learn About the Study Medicine PF-06823859 in Adults With Active CLE or SLE With Skin Symptoms | View | |
| NCT00974519 | The Effect of Combination of Traditional Chinese Medicine TCM and Highly Active Antiretroviral Therapy HAART on Immune Reconstitution of HIVAIDS Patients | View | |
| NCT00004141 | Combination Chemotherapy Plus Biological Therapy in Treating Patients With Metastatic Melanoma | View | |
| NCT01010646 | Study Comparing the Tolerability and Viral Reduction of the Combination of IFN a-2b XL Ribavirin Versus Peg IFN a-2b Ribavirin in Patients With Chronic Hepatitis C Genotype 1 or 4 | View | |
| NCT02734173 | Pilot HCV Direct Acting Antiviral Therapy and Metabolism | View | |
| NCT06016699 | Immunological Function After Radiation With Either Proton or Photon Therapy | View | |
| NCT02056587 | Everolimus in Patients With Metastatic Renal Cell Carcinoma Following Progression on Prior Bevacizumab Treatment | View | |
| NCT02622724 | Efficacy and Safety of FP-1201-lyo Interferon Beta-1a in Patients Having Acute Respiratory Distress Syndrome ARDS | View | |
| NCT01176552 | Granulocyte-macrophage Colony-stimulating Factor Interferon and Interleukin-2 as Adjuvant Treatment for Renal Cancer | View | |
| NCT01178996 | Thymosin Alpha-1 in Combination With Peg-Interferon Alfa- 2a and Ribavirin for the Therapy of Chronic Hepatitis C Nonresponsive to the Combination of IFN and Ribavirin | View | |
| NCT01185028 | A Safety and Tolerability Study of Nitazoxanide in HIV-HCV Treatment Failures | View | |
| NCT01201343 | Evaluation of Emotional Disorders During Treatment by Interferon Beta in Relapsing-remitting Multiple Sclerosis Patients | View | |
| NCT01224132 | Effect of Probiotics in the Atopic Dermatitis | View | |
| NCT01227798 | Safety and Efficacy Study of Interferon to Treat Patients Hospitalized for Influenza | View | |
| NCT06208761 | Triphala Supplementation and High-intensity Interval Exercise and Immune System Function and Oxidative Stress | View | |
| NCT06204796 | The Role of Vitamin D in Amelioration of Oral Lichen Planus and Its Effect on Salivary IFN-γ Level | View | |
| NCT00006343 | STI571 Compared With Interferon Alfa Plus Cytarabine in Treating Patients With Newly Diagnosed Chronic Myelogenous Leukemia | View | |
| NCT01237262 | Evaluation of Lymphocytic Infiltrate Dendritic Cells and Cytokines Expression in Psoriatic Lesion and Normal Skin Before and After TNF Alfa Inhibitors Therapy | View | |
| NCT01246817 | Temsirolimus-RCC-imaging | View | |
| NCT01260350 | Open-Labeled Study of PSI-7977 and RBV With and Without PEG-IFN in Treatment-Naïve Patients With HCV GT2 or GT3 | View | |
| NCT01290731 | A Study of TMC435 in Genotype 1 Hepatitis C-infected Patients Who Relapsed After Previous Interferon IFN-Based Therapy | View | |
| NCT01310205 | Extension Study SCI-SCV-HCV-P2-001 Long-Term FU in Subj Who Opt for Retreatment With Peg-INF and RBV After Completing Treatment in HCV | View | |
| NCT00205764 | Tandem High Dose Melphalan Versus Triple Intermediate Dose Melphalan and Stem Cell Transplantation in Induction Phase and PrednisoloneIFN Versus IFN in Maintenance Therapy | View | |
| NCT00008463 | A Comparison of the Effectiveness Safety and Tolerability of Two Different Hepatitis C Treatments in Patients Infected With Both HIV and Hepatitis C Virus HCV | View | |
| NCT00000696 | A Phase III Open Label Study To Evaluate the Antiviral Potential of Combination Low-Dose Therapy With Zidovudine and Interferon-Alpha 2A in Patients With Symptomatic HIV Disease | View | |
| NCT06439914 | First-in-human Study of Interferon-y PET Imaging to Assess Response to Immunotherapy | View | |
| NCT02064816 | A Study of Rebif in Subjects With Relapsing Multiple Sclerosis | View | |
| NCT02060058 | Boceprevir-based Therapy to Rescue HCV Genotype 1HBV Infected Patients Refractory to Combination Therapy | View | |
| NCT00001113 | A Study of AZT Plus Human Interferon Alpha in the Treatment of AIDS-Related Kaposis Sarcoma | View | |
| NCT00002574 | Homoharringtonine and Interferon Alfa in Treating Patients With Chronic Myelogenous Leukemia | View | |
| NCT00000725 | A Phase I Study of AZT and Human Interferon Alpha Recombinant Alpha-2A and Lymphoblastoid in the Treatment of AIDS-Associated Kaposis Sarcoma | View | |
| NCT00002763 | High-Dose or Low-Dose Interferon Alfa Compared With No Further Therapy Following Surgery in Treating Patients With Stage III Melanoma | View | |
| NCT00001509 | A Phase II Trial of All-Trans-Retinoic Acid in Combination With Interferon-Alpha 2a in Children With Recurrent Neuroblastoma or Wilms Tumor | View | |
| NCT02083042 | Clinical Validation of Lophius Biosciences Kit T-Track CMV in Kidney Transplant Recipients | View | |
| NCT02850289 | APPROACH Study Quality of Life and Outcomes Assessment in Participants With Chronic Hepatitis C CHC Treated With Pegylated Interferon PEG-IFN Alfa-2a and Ribavirin | View | |
| NCT00001114 | The Safety and Effectiveness of Interferon Alfa-2B Plus Didanosine in Patients With Kaposis Sarcoma | View | |
| NCT00006385 | Vaccine Therapy With or Without Biological Therapy in Treating Patients With Metastatic Melanoma | View | |
| NCT01241760 | VX-950-C211 - A Dosing Regimen Study Twice Daily Versus Every 8 Hours of Telaprevir in Treatment-naïve Participants With Genotype 1 Chronic Hepatitis C Virus Infection | View | |
| NCT02099604 | Efficacy and Safety of the Combination Vitamin D With Standard of Care in Egyptian Patients With Untreated Chronic Hepatitis C | View | |
| NCT00003561 | Interferon Alfa Plus Sargramostim in Treating Patients With Newly Diagnosed Chronic Phase Chronic Myelogenous Leukemia | View | |
| NCT00005012 | Safety and Effectiveness of PEG-Intron in HIV-Infected Patients | View | |
| NCT01545141 | Chemokine-Modulatory Regimen for Recurrent Resectable Colorectal Cancer | View | |
| NCT00002433 | The Effects of r-metHuIFN-Gamma on the Lungs of Patients With AIDS | View | |
| NCT00203879 | Study of MAGE-3Melan-Agp 100NA17 and rhIL-12 WithOut Low Dose IL-2 in Metastatic Melanoma | View | |
| NCT00813709 | Long-term Follow-Up of Patients Who Participated in Study 27025 REFLEX | View | |
| NCT00780416 | Efficacy and Safety of MP-424Peginterferon Alfa-2bRibavirin Combination in Treatment-Naïve Patients With Chronic Hepatitis C | View | |
| NCT00735007 | 12-week Study to Evaluate RebiSmart Suitability for Self Injection in Relapsing Multiple Sclerosis | View | |
| NCT02951611 | Effects of Acupuncture Stimulation on Systemic Inflammation | View | |
| NCT02125695 | Pilot Tape Harvesting Study | View | |
| NCT00333840 | Safety and Efficacy of Imatinib Versus Interferon-α Plus Cytarabine in Patients With Newly Diagnosed Philadelphia Chromosome Positive Chronic Myelogenous Leukemia | View | |
| NCT01401400 | Genetic Study of Peginterferon Treatment in Hepatitis B Patients The GIANT-B Study | View | |
| NCT02123654 | UNITY 3 A Japanese Phase 3 Study of a DaclatasvirAsunaprevirBMS-791325 in Subjects With Genotype 1 Chronic Hepatitis C | View | |
| NCT02128217 | Sofosbuvir-Containing Regimens Without Interferon For Treatment of Acute Hepatitis C Virus HCV Infection | View | |
| NCT00751426 | Treatment of Hepatitis C in Psychiatric Patients | View | |
| NCT00703118 | A Safety and Effectiveness Study of Telaprevir in Chronic Genotype 1 Hepatitis C Patients That Failed Previous Standard Treatment | View | |
| NCT00003239 | Chemotherapy and Biological Therapy in Treating Patients With Chronic Phase Chronic Myelogenous Leukemia | View | |
| NCT00763295 | Is Tuberculin Skin Testing Effective in Screening for Latent Tuberculosis in Patients With HIV | View | |
| NCT02151448 | αDC1 Vaccine Chemokine Modulatory Regimen CKM as Adjuvant Treatment of Peritoneal Surface Malignancies | View | |
| NCT02416154 | Expression of IFN-epsilon in the Female Reproductive Tract | View | |
| NCT00047658 | A Study of the Safety and Clinical Effects of Interferon Gamma-1b in Patients With Idiopathic Pulmonary Fibrosis IPF | View | |
| NCT00000967 | The Safety of Zidovudine Plus Interferon-Alpha in HIV-Infected Children | View | |
| NCT02150291 | A Pilot Study to Assess the Efficacy and Safety of Folic Acid andor Vitamin B Complex on Hepatitis C Infected Patients Treated With Pegylated Interferon and Ribavirin | View | |
| NCT02156479 | Clinical Validation of Lophius Biosciences Kit T-Track CMV in Allo-HSCT Recipients | View | |
| NCT01272310 | Clinical Trial to Assess Safety and Efficacy of Combination Therapy Hydroxychloroquine Pegylated Interferon Alpha-2a and Ribavirin in Chronic Hepatitis C Subjects Non-responders to the Standard of Care Therapy | View | |
| NCT01404936 | Study of a-Interferon With Adriamycin Bleomycin Velban and Dacarbazine ABVD With Hodgkins Disease | View | |
| NCT00002669 | Combination Chemotherapy Interferon Alfa and Interleukin-2 in Treating Patients With Metastatic Melanoma | View | |
| NCT02573025 | A Bioequivalence Study of Pegylated Interferon Alfa-2a PEG-IFN Alfa-2a Benzyl Alcohol BA-Free Formulation Versus PEG-IFN Alfa-2a Pegasys Following Subcutaneous Administration | View | |
| NCT00002018 | Double-Blind Randomized Dose Ranging Study of Alferon LDO Low Dose Oral Interferon Alfa-n3 Human Leukocyte Derived in HIV Subjects | View | |
| NCT00004804 | Phase III Randomized Study of High Vs Standard Dose of Interferon Alfa for Chronic Hepatitis C | View | |
| NCT00000754 | A Randomized Phase II Study of Two Doses of Interferon Alfa-2a IFN Alfa-2a in Combination With Zidovudine AZT and Dideoxycytidine ddC Versus AZT and ddC Only in Patients With HIV Infection and Less Than 400 CD4 Cellsmm3 | View | |
| NCT02175134 | IFN-gamma-releasing Assay Based Approach in Patients With Suspected Tuberculous Peritonitis | View | |
| NCT00001112 | The Safety and Effectiveness of Injections of Human Recombinant Interferon-gamma in Patients With AIDS Who Have Taken Zidovudine | View | |
| NCT00278174 | Interferon Alfa IFN-Alpha-1b in Renal Cancer With Metastatic Kidney Cancer | View | |
| NCT00297232 | Natalizumab Tysabri Re-Initiation of Dosing | View | |
| NCT00831207 | Beta-2 Microglobulin and Serum Cytokines x HAART | View | |
| NCT00291369 | Cytokines in Patients With Metastatic Renal Cell Carcinoma of Intermediate Prognosis | View | |
| NCT00000764 | Chemoprevention of Anal Neoplasia Arising Secondary to Anogenital Human Papillomavirus Infection in Persons With HIV Infection | View | |
| NCT02197169 | DNX-2401 With Interferon Gamma IFN-γ for Recurrent Glioblastoma or Gliosarcoma Brain Tumors | View | |
| NCT00880763 | A Study of Safety and Efficacy of Vaniprevir Administered With Pegylated-Interferon and Ribavirin in Japanese Participants With Chronic Hepatitis C Infection 7009-016 | View | |
| NCT00000647 | An Open Trial Combining Zidovudine Interferon-alfa and Recombinant CD4-IgG With Transplantation of Syngeneic Bone Marrow and Peripheral Blood Lymphocytes From Healthy gp160-Immunized Donors in the Treatment of Patients With HIV Infection | View | |
| NCT02201459 | Nilotinib Peg-IFN for First Line Chronic Phase CML Patients | View | |
| NCT00913913 | Bevacizumab Autologous TumorDC Vaccine IL-2 and IFNα-2b in Metastatic Renal Cell Carcinoma RCC Patients | View | |
| NCT02214420 | SMV SOF WithWithout RBV for IFN-II Patients With CHC | View | |
| NCT02594293 | Pegylated InterferonPeg-IFN in Reducing Relapse Rate in Patients After Discontinuation of NUC Therapy | View | |
| NCT01073436 | Discontinuation of Imatinib Mesylate in Patients With Chronic-Phase Chronic Myeloid Leukemia Previously Treated With Interferon-Alpha | View | |
| NCT02227277 | Reducing Proviral HIV DNA With Interferon-a | View | |
| NCT01252355 | Efficacy and Safety of Teriflunomide in Patients With Relapsing Multiple Sclerosis and Treated With Interferon-beta | View | |
| NCT01273948 | Pilot Trial of Bavituximab Combined With Ribavirin for Initial Treatment of Chronic HepC Virus Genotype 1 Infection | View | |
| NCT01291381 | Distinct Response of CD4CD25Foxp3 and IL-10-secreting Type I T Regulatory Cells to Cluster Specific Immunotherapy in Allergic Rhinitis Children | View | |
| NCT02243280 | A Study to Evaluate the Efficacy Safety and Pharmacokinetics of Co-administration of ABT-493 and ABT-530 With and Without Ribavirin in Subjects With HCV Genotype 1 4 5 and 6 Infection | View | |
| NCT01359384 | Bronchial Inflammation in Patients With Severe Immune Deficiency Under Immunoglobulin Treatment | View | |
| NCT01370642 | Vaniprevir Administered With Pegylated-interferon and Ribavirin in Japanese Treatment-Naïve Chronic Hepatitis C Participants MK-7009-043 | View | |
| NCT01405937 | Study of Vaniprevir Plus PegIntronRibavirin in Japanese Participants With Chronic Hepatitis C Who Relapsed After Treatment MK-7009-044 | View | |
| NCT01405560 | Vaniprevir Plus PegIntronRibavirin in Japanese Participants With Chronic Hepatitis C Who Are Non-responders to Previous Treatment MK-7009-045 | View | |
| NCT01433770 | Alefacept in Kidney Transplant Recipients | View | |
| NCT01440595 | Grazoprevir MK-5172 With Peg-Interferon and Ribavirin in Participants With Chronic Genotype 2 or 3 Hepatitis C MK-5172-012 | View | |
| NCT01457937 | BoceprevirPegIFN α-2bRiba in HCV Gt1 Menopausal Women Nonresponders to PegIFNRiba or Treatment-naives MEN_BOC | View | |
| NCT01490853 | Follow-up of Ph Chronic Myleoid Leukemia Patients in Complete Cytogenetic Response With Interferon Based Therapy | View | |
| NCT01492478 | Psychobiological Characterization of Depression in Hepatitis C | View | |
| NCT01498068 | Open-Label Bridging Study of Telaprevir in Treatment-Naïve and Treatment-Experienced Russian Patients With Genotype 1 Chronic Hepatitis C | View | |
| NCT01502696 | Adjuvant PEG Intron in Ulcerated Melanoma | View | |
| NCT01544920 | Safety and Efficacy of BoceprevirPeginterferon Alfa-2aRibavirin in Interleukin-28B CC Allele-Positive Chronic Hepatitis C Virus HCV Genotype 1 Participants P07755 | View | |
| NCT05332067 | Omalizumab Before Onset of Exacerbations | View | |
| NCT05440422 | The Role of Anifrolumab in Improving Markers of Vascular Risk in Patients With Systemic Lupus Erythematosus SLE - IFN-CVD | View | |
| NCT05450289 | The Efficacy of Nigella Sativa in Children With House Dust Mite-Induced Respiratory Allergy Receiving Immunotherapy | View | |
| NCT05546632 | Evaluation of Cyto-chex Tubes for the Measurement of Monocyte Expression of Human Leukocyte Antigen - DR Isotype HLA-DR Molecules by Flow Cytometry | View | |
| NCT00000687 | Phase II Study of Zidovudine and Recombinant Alpha-2A Interferon in the Treatment of Patients With AIDS-Associated Kaposis Sarcoma | View | |
| NCT00031083 | Dose Escalation Study to Determine the Safety of IFN-Beta Gene Transfer in the Treatment of Grade III Grade IV Gliomas | View | |
| NCT00108563 | VISN 20 Prophylactic Treatment of Interferon-Induced Depression in Hepatitis C Patients | View | |
| NCT02283450 | Regulation of Immunological Cytokines by Qiliqiangxin Capsule in Dilated Cardiomyopathy Patients | View | |
| NCT00120133 | Atorvastatin Lipitor to Prevent Bone Pain | View | |
| NCT00178698 | HyperthermiaThermal Therapy With Chemotherapy to Treat Inoperable or Metastatic Tumors | View | |
| NCT00221702 | PegIntron Versus IntronA in CMAJCC Stage II EADO 2001CMII Trial | View | |
| NCT00223301 | Safety Study of Combination Therapy With Intramuscular Avonex and Oral Cellcept in Patients With Multiple Sclerosis | View | |
| NCT00277238 | CPG10101 Combination Therapy For The Treatment Of Hepatitis C In Non-Responder Null And Partial Responder Hepatitis C Virus HCV Genotype 1 Infected Subjects | View | |
| NCT02315755 | Observational Study Evaluating The Efficacy And Effects On Quality Of Life Of Targeted Treatments Following TKIs In mRCC | View | |
| NCT02328755 | Peginterferon Alfa-2a to Enhance Anti-leukemic Responses After Allogeneic Transplantation in Acute Myeloid Leukemia | View | |
| NCT00001004 | A Study of Tumor Necrosis Factor and Human Interferon-gamma in Patients With AIDS Related Complex | View | |
| NCT00001547 | Neuropsychiatric Effects of Interferon-Alpha and Ribavirin | View | |
| NCT00072943 | A Humanized Anti-Interferon-γ Monoclonal Antibody HuZAF for Moderate to Severe Crohns Disease | View | |
| NCT00082862 | Cisplatin Metronomic Low-Dose Interferon Alfa Gemcitabine and Fever-Range Whole-Body Hyperthermia in Treating Patients With Inoperable or Metastatic Pancreatic Cancer | View | |
| NCT00084279 | CIFN and IFN γ-1b With or Without Ribavirin for Treatment of Chronic Hepatitis C Nonresponders | View | |
| NCT00101959 | Implementation Study of Treatment Optimization Recommendations on Relapsing-Remitting Multiple Sclerosis RR MS Subjects | View | |
| NCT00114361 | 48 Weeks Combination Therapy for Patients With HBeAg-negative Chronic Hepatitis B Virus HBV Infection | View | |
| NCT00204529 | Pegylated Interferon-alpha-2a in Patients With Malignant Melanoma Stage IIA-IIIB | View | |
| NCT00234182 | Postoperative Adjuvant Therapy With Recombinant Interferon-Alpha Following Curative Resection of HCC | View | |
| NCT00255359 | Safety Tolerability and Efficacy of XTL 2125 in HCV-Infected Patients Who Are Interferon-Alpha Non-Responders or Relapsers | View | |
| NCT00275886 | Activation and Recruitment of GIL During Hp Infection | View | |
| NCT00299923 | Study for Patients With Chronic HCV GT 1 or 3 Who Relapsed to Previous PegInterferon Ribavirin Combination Therapy | View | |
| NCT00306592 | Natalizumab Re-Initiation of Dosing | View | |
| NCT00317746 | Trial of Citalopram for the Prevention of Depression | View | |
| NCT00357045 | Antidepressant Prophylaxis for Interferon-Induced Depression Efficacy of Paroxetine | View | |
| NCT00353821 | Investigating Cytokine Genes of Stem Cell Donors | View | |
| NCT00373412 | Trial of pDNA CMV Vaccine VCL-CT02 Followed by Towne CMV Vaccine Towne Challenge | View | |
| NCT00398528 | An fMRI Study of Treatment Optimization Comparing Two Disease Modifying Therapies Used to Treat Relapsing Remitting Multiple Sclerosis | View | |
| NCT00391352 | fMRI Study of Treatment Recommendations Comparing Recently Diagnosed Multiple Sclerosis MS Patients to Controls | View | |
| NCT00394693 | Study to Evaluate the Safety and Efficacy of Adeno-IFN Gamma in Cutaneous B-cell Lymphoma | View | |
| NCT00402428 | Efficacy of Albumin Interferon Alfa-2b With Ribavirin Compared With Peg-IFN Alfa-2a With Ribavirin in IFN Naive Patients | View | |
| NCT00420888 | ABR-217620Naptumomab Estafenatox With Interferon-alpha IFN-alpha Compared to IFN-alpha Alone in Patients With Advanced Renal Cell Carcinoma | View | |
| NCT00436826 | A Phase 2 Study of Cladribine Add-on to Interferon-beta IFN-beta Therapy in Multiple Sclerosis MS Subjects With Active Disease ONWARD | View | |
| NCT00437684 | LopinavirRitonavir Monotherapy Versus Standard Highly Active Antiretroviral Therapy HAART in HIVHCV Coinfected Patients Starting Treatment With Anti-Hepatitis C Virus HCV Therapy | View | |
| NCT00437476 | LopinavirRitonavir Monotherapy Versus Standard Highly Active Antiretroviral Therapy HAART in HIVHCV Coinfected Antiretroviral ARV Naive Patients Starting Treatment With Anti-HCV Therapy | View | |
| NCT00528528 | An Open-Label Study of Telaprevir Administered Every 12 or 8 Hours in Combination With One of Two Pegylated Interferons and Ribavirin in Treatment-Naive Genotype 1 Chronic Hepatitis C Participants | View | |
| NCT00538811 | Interferon-gamma With Interferon Alpha and Ribavirin for Hepatitis C Non-responders | View | |
| NCT00577993 | Fludarabine Mitoxantrone and Dexamethasone FND Plus Rituximab for Lymphoma Patients | View | |
| NCT00573378 | Imatinib or Nilotinib With Pegylated Interferon-α2b in Chronic Myeloid Leukemia | View | |
| NCT00594880 | Antiviral Activity of Peg-IFN-Alpha-2A in Chronic HIV-1 Infection | View | |
| NCT00612755 | Efficacy and Safety to Extend Treatment 24 Weeks in co-Infected HIV-HCV Genotype 1 andor 4 | View | |
| NCT00624325 | Subcutaneous Continuous Infusion of Interferon Alfa-2b and Ribavirin in Hepatitis C Genotype 1 Nonresponders | View | |
| NCT00629200 | Sodium Stibogluconate With Interferon Alpha-2b for Patients With Advanced Malignancies | View | |
| NCT00679289 | Phase II Study of KW2871 Combined With High Dose Interferon-α2b in Patients With Metastatic Melanoma | View | |
| NCT00677547 | Cell-mediated Immune Response to Influenza Vaccine | View | |
| NCT00686881 | Efficacy of Peginterferon Alfa-2b SCH 054031 vs Glycyrrhizin in Interferon IFN-Treated Patients With Chronic Hepatitis C and F2F3 Liver Fibrosis P04773 | View | |
| NCT00686478 | Intron A for the Treatment of Hypertrophic Scar | View | |
| NCT00704184 | Safety and Efficacy of Vaniprevir MK7009 Administered With Pegylated-Interferon and Ribavirin MK-7009-007 | View | |
| NCT00703872 | HDV-Interferon in the Treatment of Chronic Hepatitis C Nonresponders and Naive Hepatitis C Patients | View | |
| NCT00724061 | Study of Pegylated Interferon-Alfa 2b in Combination With PUVA Therapy In CTCL | View | |
| NCT00724230 | Safety and Efficacy of PegIntron Plus Rebetol in Patients With Chronic Hepatitis C in Japan Excluding 1 Subjects With HCV Genotype 1 and High Viral Load and 2 Interferon-naïve Subjects With Low Viral Load Study P04841COMPLETED | View | |
| NCT00724620 | PEG-IFN Alfa-2b Plus Ribavirin for Treatment of Mexican naïve Patients With Chronic Hepatitis C Infected With Genotype 1 Study P04511COMPLETED | View | |
| NCT00756808 | Is Tuberculin Skin Testing Effective in Screening for Latent Tuberculosis TB in Elderly Residents of Nursing Homes | View | |
| NCT00796757 | A Study of Avastin Bevacizumab in Combination With Low-Dose-Interferon in Patients With Metastatic Clear Cell Renal Cell Carcinoma RCC | View | |
| NCT00803309 | Study to Assess the Efficacy of 12 Versus 24 Weeks of Extended Treatment in HCV-Genotype 23 Patients | View | |
| NCT02498808 | Interferon-lambda Novel Biologics for Controlling Neutrophil-mediated Pathology in Rheumatic Diseases | View | |
| NCT02532907 | Study of Hepatic Responses in Patients Receiving Direct-acting Anti-HCV Drugs | View | |
| NCT02568787 | The Effect of an RBAC Supplement BRM4 on NAFLD | View | |
| NCT02578693 | Follow up of IFN Vs DAAs HCV SVR IFDACS Study | View | |
| NCT02587065 | Plegridy Satisfaction Study in Participants | View | |
| NCT02666768 | ACTIMMUNE in Intermediate Osteopetrosis | View | |
| NCT02690675 | Iron Supplement Effect on Child Development | View | |
| NCT02716779 | Influence of Ribavirin on the Initial Virological Response in Treatment Naïve Patients With Hepatitis C Genotype 1 Infection | View | |
| NCT02739048 | Changes of Immunologic Function in Patients of Prostate Cancer Induced After Cryoablation | View | |
| NCT02749396 | EPID Multiple Sclerosis Pregnancy Study | View | |
| NCT02773849 | ADSTILADRIN INSTILADRIN in Patients With High-Grade Bacillus Calmette-Guerin BCG Unresponsive Non-Muscle Invasive Bladder Cancer NMIBC | View | |
| NCT02802280 | Endothelial Dysfunction and Subclinical Atheromatosis in Chronic HCV Infection Response to DAA Agents | View | |
| NCT02806362 | Study of OmbitasvirParitaprevirRitonavir in Japanese Adults With Genotype 1b Chronic Hepatitis C Virus HCV Infection With End Stage Renal Disease ESRD on Hemodialysis HD | View | |
| NCT02837939 | Transfer Factor Efficacy in the Management of Cirrhosis-associated Immune Dysfunction | View | |
| NCT02856243 | Direct Antiviral Agents for Hepatitis C Virus-associated Cryoglobulinaemia Vasculitis | View | |
| NCT02874066 | PrOD for Non-Cirrhotic Patients With HCV-1b Receiving Hemodialysis | View | |
| NCT02898922 | Robust Antibody and Cytokine Response to Hepatitis B Vaccine Among Not-in-treatment Patients With Chronic Hepatitis CAn Open-label Control Study in China | View | |
| NCT02893124 | The Optimizing Treatment of Peginterferon PEG IFN Alpha in Chronic Hepatitis B Virus Patients With Low Level HBsAg | View | |
| NCT02962960 | A Study to Characterize the Pharmacokinetics Pharmacodynamics and Safety of Anifrolumab in Adult Type I Interferon Test High Systemic Lupus Erythematosus Subject With Active Skin Manifestations | View | |
| NCT03049579 | Immune System Stimulation by Probiotic Food Supplementation | View | |
| NCT03059966 | Evaluation of the Inflammatory and Healing Profile After Root Coverage With Emdogain | View | |
| NCT03208998 | The Changes of Natural Killer Cells Frequency and Function During Antiviral Therapy | View | |
| NCT03235349 | Efficacy and Safety of GlecaprevirPibrentasvir ABT-493ABT-530 in Treatment-Naive and Treatment-Experienced Asian Adults With Chronic Hepatitis C Virus Genotype GT 1 to GT6 Infection With Compensated Cirrhosis and With or Without Human Immunodeficiency Virus Co-Infection | View | |
| NCT03244371 | Analysis of the Impact of HCV Treatment by Last Generation Direct Antiviral Agents DAA on Antiviral Immunity and HIV DNA Reservoir in Coinfected HIV-HCV Patients | View | |
| NCT03313102 | Study of T Lymphocytes in Patients With Horton Disease | View | |
| NCT03311854 | A Study to Investigate the Safety and Efficacy of Emapalumab an Anti-IFN-gamma mAb in Patients With Systemic Juvenile Idiopathic Arthritis sJIA or Adult-onset Stills Disease AOSD Developing Macrophage Activation SyndromeSecondary HLH MASsHLH | View | |
| NCT03337165 | Autologous Tolerogenic Dendritic Cells for Treatment of Patients With Rheumatoid Arthritis | View | |
| NCT03465397 | Individualization of the Immunological Risk Based on Selective Biomarkers in Living-donor Renal Recipients | View | |
| NCT03588715 | Peg-Interferon Alpha 2b Combined With Two Intravenous Broadly HIV-1 Neutralizing Antibodies 3BNC117 and 10-1074 BEAT-2 | View | |
| NCT03638375 | TIL and Anti-PD1 in Metastatic Melanoma | View | |
| NCT03665766 | Effect of Cyclosporine A Versus Tacrolimus on Response to Antiviral Therapy After Hepatitis C Genotype -4 Recurrence Post Liver Transplantation | View | |
| NCT03719313 | Study of the Efficacy and Safety of Lonafarnib Ritonavir With and Without Pegylated Interferon -Alfa-2a | View | |
| NCT03710876 | Efficacy Safety of rAd-IFN Administered With Celecoxib Gemcitabine in Patients With Malignant Pleural Mesothelioma | View | |
| NCT03772847 | Ginkgolide With Intravenous Alteplase Thrombolysis in Acute Ischemic Stroke Neurological Improving Trial | View | |
| NCT03902392 | Red Grape Polyphenol Oral Administration to Women Affected by Nickel-mediated Allergic Contact Dermatitis | View | |
| NCT03957629 | Optimized Treatment of Peginterferon Alfa 2a in Treatment Experienced Patients With HBV Related Liver Fibrosis | View | |
| NCT03969017 | Combination Treatment of NAs and Peg IFN α-2b for Hepatitis B Related Compensatory Cirrhosis Patients | View | |
| NCT03985423 | A Study to Evaluate the Efficacy Safety and Pharmacokinetics of Emapalumab in Adult Patients With HLH | View | |
| NCT04116502 | MITHRIDATE Ruxolitinib Versus Hydroxycarbamide or Interferon as First Line Therapy in High Risk Polycythemia Vera | View |